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There is a growing interest in micro sized vehicles with the function of storing, 
targeting and controlled releasing of substances during the past few decades. 
However, delivering the desired drugs inside micro containers to living cells is 
a particular challenging topic of material science. Microcapsules made of 
polyelectrolyte multilayers exhibit low- or non-toxicity, appropriate mechanical 
stability, variable degradation and can incorporate remotely addressable 
release mechanisms in responding to stimuli and external triggering, making 
them well suitable for targeted drug delivery to live cells. This study 
investigates interactions between microcapsules made of synthetic (i.e. 
PSS/PAH) or natural (i.e. DS/PArg) polyelectrolyte and cells, with particular 
focus on the effect of the glycocalyx layer on the intake of microcapsules by 
human umbilical vein endothelial cells (HUVECs). Neuraminidase cleaves 
N-acetyl neuraminic acid residues of glycoproteins and targets the sialic acid 
component of the glycocalyx on the cell membrane. Three-dimensional 
CLSM images reveal that microcapsules functionalized with neuraminidase 
can be internalized by endothelial cells, whereas ones without neuraminidase 
are blocked by the glycocalyx layer. Uptake of the microcapsules is most 
significant in the first 2 hours. Following their internalization by endothelial 
cells, biodegradable DS/PArg capsules rupture by day 5, however, there is 
no obvious change in the shape and integrity of PSS/PAH capsules within the 
period of observation. Results from the study support our hypothesis that the 
glycocalyx functions as an endothelium barrier to cross membrane 
movement of microcapsules. Neuraminidase-loaded microcapsules can enter 
endothelial cells by cleaving the glycocalyx in their close proximity with 
minimum disruption of the glycocalyx layer, therefore they have high potential 
to act as drug delivery carriers to pass through the endothelium barrier of 
blood vessels into the surrounding tissue.  
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Various drug delivery systems have been developed over last several 
decades with numerous applications in biomedical science which are (De 
Cock, De Koker et al. 2010; De Koker, Lambrecht et al. 2011; Vergaro, 
Scarlino et al. 2011) reported in high impact publications. Modern drug 
delivery systems lead to a significant improvement in the research and 
pharmaceutical industry. Compared to the conventional drug delivery 
methods, modern drug delivery is more biocompatible and controllable.  
When a polymer is combined with a drug or active agent which is mean the 
release from the bulk material is pre-designed, and controlled drug delivery 
becomes a reality. As the name implies, it is delivering a defined quantity of a 
therapeutic payload to a specific target site, at a controlled release rate, with 
or without external trigger (Langer and Tirrell 2004).  
Nanometer- or micron-sized small particles are potent materials in the 
fields of bio-technology and bio-nanotechnology. When these particles 
penetrate into the living body, they are able to play various roles in 
biomedical and clinical applications. Some drugs have an advantage in 
intracellular target as they are enhancing the therapeutic efficiency while 
avoiding severe side effects, but disadvantages in cell uptake especially 
limited solubility in a soluble solution. There is a growing interesting in micro 
sized vehicles with the function of storing, targeting and controlled releasing 
of substances during the past few decades. But delivering the desired drugs 
inside micro containers to living cells is a particular challenging topic in 
material science.  
A potential micro sized microcapsule as drug containing vesicles with 
controlled delivery and releasing to designated sites has been introduced 
over past decade (De Geest, Dejugnat et al. 2006; De Geest, Sukhorukov et 
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al. 2009). Polyelectrolyte multilayer materials have significantly affected the 
development of drug delivery due to its easily tunable properties such as 
biocompatibility, size, conformation and functionality. Microcapsules made 
from polyelectrolyte multilayers exhibit low- or non -toxicity, appropriate high 
mechanical stability, and variable degradation and stimuli responsive 
remotely addressable releasing mechanisms. Therefore, microcapsules are 
well suitable for targeting drug delivery to living cells.  
A novel type of hollow microcapsules ranging in size from 60 nanometers 
to more than 10 micrometers is constructed using the Layer-by-Layer (LbL) 
technique. Figure 1 shows the fabrication of polyelectrolyte multilayer 
capsules using LbL technique. Oppositely charged substances such as 
proteins (Lvov, Ariga et al. 1995), polyelectrolytes (Decher 1997), 
nanoparticles (Caruso, Caruso et al. 1998), lipids (Moya, Donath et al. 2000), 
and nanotubes (Mamedov, Kotov et al. 2002) sequentially absorbed onto a 
charged template by electrostatic attraction, resulting in complex formation 
between polyanions and polycations (Sukhorukov, Donath et al. 1998). The 
hollow capsule is called polyelectrolyte multilayer microcapsule, and is 
obtained after decomposing the template core under certain conditions. The 
size and morphology of the capsules, the polyelectrolytes and thickness of 
the shell, the permeability properties as well as release activation mechanism 
(Sukhorukov, Rogach et al. 2007) can be well controlled with LbL method.  
Several kinds of organic and inorganic materials have been used as 
colloidal template cores to fabricate hollow polyelectrolyte microcapsules. 
The main problems of the template core is that they are toxic, and hazardous 
solutions or chemicals are required during capsules fabrication (Gao, Moya et 
al. 2002). For example dissolution step of melamine formaldehyde (MF) 
oligomers formed capsules is biological incompatible. Therefore, 
encapsulation and core dissolution must be done under certain conditions 
 15 
 
without extremely low or high pH, oxidizing agents, hydrofluoric acid, or 
organic solvents. Obviously, such conditions are able to influence the 
biological activities and damage sensitive biomolecules. Encapsulation of 
bioactive materials with a biocompatible template under appropriate 
conditions becomes a problem. 
 
Figure 1: Schematic illustration of fabricate polyelectrolyte multilayer capsules with 
layer-by-layer technique 
A) - D) These steps show consecutive formation of the polyelectrolyte layer film by repeated 
exposure of the template core (such as MF, CaCO3 and PS) to polymers solution with 
alternating interactions. The unformed polymer is removed by 3 times of centrifugation and 
washing steps before exposure of the template cores to the next layer’s polymer solution. E) 
After the desired numbers of polymer layers are deposited, the template cores are 
decomposed. F) After further washing steps, a suspension of hollow polyelectrolyte 
multilayer microcapsules are fabricated. (Donath, Sukhorukov et al. 1998) 
Recently, nontoxic core of CaCO3 colloidal templates have been used to 
produce hollow polyelectrolyte microcapsules. Core of CaCO3 can be easily 
dissolved by 0.2 M ethylenediaminetetraacetic acid (EDTA). Most importantly, 
CaCO3 particles are easily to be synthesized from Na2CO3 and CaCl2 
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solution (Na2CO3+CaCl2=CaCO3↓+2NaCl). They are able to fill with 
macromolecules up to a size of 40 nm due to their high porosity (Volodkin, 
Larionova et al. 2004). 
The walls of microcapsule are established have semipermeable properties 
(Sukhorukov, Brumen et al. 1999). The permeability of the capsules has been 
studied using fluorescent dye as a release reagent (Antipov, Sukhorukov et al. 
2001). The capsules permeability can be modified further using parameters, 
such as pH value (An, Möhwald et al. 2006), charge (Tong, Dong et al. 2005), 
salt concentration (Georgieva, Dimova et al. 2005), temperature (Köhler and 
Sukhorukov 2007) and ionic strength (Gao, Leporatti et al. 2003). The 
permeability of drug coated crystals is strongly influenced by the number of 
deposited multilayers. The temporal drug release rate is controlled by the 
layers, which can be tuned in the nanometer range. The composition of the 
capsules shell include innermost layer, outermost layer or between layers 
can additionally provide appropriate functionalities, for instance magnetic 
(Zebli, Susha et al. 2005), optical (Bédard, Skirtach et al. 2007), conductive, 
or targeting properties. After all, different kinds of biomaterials have been 
used to encapsulate, coat, and functionalize polyelectrolyte multilayer 
microcapsules. 
In recent few years, numbers of natural polyelectrolytes and polypeptides 
have been used to fabricate biodegradable microcapsules. These 
biodegradable microcapsules are successfully internalized by several 
phagocytic cells like most cancer cells and immune cells (Sukhorukov, 
Rogach et al. 2005; De Geest, Vandenbroucke et al. 2006). The mechanisms 
of the living cells internalize microcapsules are not fully understood, however 
the natural endocytosis of the cells is one of believed to play an important 
role. So far, no report on microcapsules internalization and/or degradation by 
non-phagocytic cells has been published. The microcapsules could be 
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attracted, adhered and internalized by normal healthy cells result the delivery 
of drugs with an intracellular target.  
The aim of this thesis consists in investigation of the interactions between 
microcapsules and cells. Functionalization of capsules is studied at the 
beginning. Capsules shell is modified with gold nanoparticles and magnetite 
nanoparticles for better contrast in SEM observation and external magnetic 
field, respectively. Investigation of interactions between magnetic 
microcapsules and epithelial cells is cooperated with Dr Maya Thanou 
(pharmacy department of King's College London). Capsules with and without 
magnetite nanoparticles are added to these cells with a magnet under the 
well. The capsules with magnetite are attracted to the bottom of the container 
by additional driving force. Confocal Laser Scanning Microscopy (CLSM) 
images show number of capsules adhered on the cells. 
Chapter of introduction and literature review present scientific background 
for better understanding of the following works. Materials and methods used 
in the investigations are briefly introduced. The followed three chapters are 
results sections which show details of the research. Chapter 6 looks at the 
preparation of microcapsules. Fluorescent dyes, neuraminidase and DNA 
plasmids are encapsulated by CaCO3 co-precipitation method. Capsules are 
prepared by “Layer-by-Layer” technique, and functionalized with colloidal 
gold nanoparticles or super paramagnetic iron nanoparticles.  
The primary aim of this work is presented in chapter 7 and 8. In chapter 7, 
investigating interactions between epithelial cells (Caco-2 cell line) and 
capsules with magnetite nanoparticles is performed with physical method. 
After few minutes of magnet treatment, number of capsules with magnetite 
nanoparticles adhered by Caco-2 cells is much higher than control sample. 
In chapter 8, interactions between capsules and human umbilical vein 
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endothelial cells are investigated with a chemical named neuraminidase. The 
main experiment is focus investigation of the role of the glycocalyx of Human 
Umbilical Vein Endothelial Cells (HUVECs) on trans-membrane transport of 
microcapsules in vitro. In order to stimulate capsule uptake, the 
microcapsules are functionalized with an enzyme namely neuraminidase, 
which has the ability to cleave N-acetyl neuraminic acid residues of 
glycoproteins and targets specifically the sialic acid component of the 
glycocalyx layer on the cell membrane surface. Neuraminidase is 
encapsulated by CaCO3 co-precipitated method. After part of the glycocalyx 
is removed, channels that allowing the passage of capsules through the cell 
membrane becomes accessible. The neuraminidase encapsulation efficiency 
and release rate are investigated with UV visible spectrometer. Degradation 
rate of capsules after their internalization by HUVECs are observed up to 7 
days. Four layered biodegradable DS/PArg capsules are observed to rupture 
into pieces by day 5, however, there is no obvious changes in the shape of 
PSS/PAH capsules within the period of time observed. Transfection of 
HUVECs by DNA plasmid and neuraminidase loaded capsules and 




2 Literature review 
This part of the report provides the scientific background to the reader for 
better understanding with the nature, functions and properties of the field 
investigated. 
2.1 Polyelectrolytes 
  Polyelectrolytes are a group of macromolecules having both properties of 
polymers and electrolytes. In 1950s, Fuoss et al found complexes like 
precipitates can be formed between polycations and polyanions (Fuoss and 
Cathers 1947). Later, Michaels tested different types of polyelectrolytes, salt 
concentrations, and charge ratios to forming spherical complexes in 
nano-size range from 20 nm to 40 nm (Michaels 1965). Then, 
polyelectrolytes constructed layer conformations was discovered by Decher 
et al (Decher and Hong 1991a).  
The term polyelectrolyte represents a polymer system that formed by 
macromolecule of charged or ionizable monomer units and low molecular 
weight counter ions, and maintain electrical neutrality (H. Dautzenberg 1994). 
Special structures of charged polymers play important roles in the forming of 
polypeptides, proteins, Glycosaminoglycans (GAG) and DNA in biological 
processes (Manning 1978). Two types of oppositely charged polyelectrolytes 
are polycations with positive charge and polyanions with negative charge. 
Because zwitterionic polymers can be varied between cationic and anionic 
forms, the special type of polyelectrolytes contains both negative and positive 
functional groups are called polyampholytes. 
Polar solvents are composed of polar molecules like liquid ammonia. 
Because the dissociation of the ions from the charged groups, they are able 
to dissolve ionic compounds or ionize part of covalent compounds of 
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polyelectrolytes. Polyelectrolytes can be classified as weak or strong types. 
When a polyelectrolyte dissociates completely in an aqueous media for most 
reasonable pH values, it is classified as strong. Furthermore, their charge 
density is mostly independent on the solution pH. Compare with strong 
polyelectrolyte, the weak one is partially dissociated over a large pH range. 
Moreover, their charge is varied as the solution pH, counterions 
concentration, or ionic strength changing. In a dilute solution, an ionizable 
molecule under acid - base equilibrium is shown in equation 2.1, the ion pair 
HA could dissociate into cationic and anionic part, and the process could be 
reversed. 
H A ⇋ H + + A -   (Eq. 2.1) 
For weak polyelectrolytes, the charge density depends on the strength of 
the poly-acid or poly-base. The dissociation behavior of each functional 
group along the chain is depend on the dissociation behavior of its nearest 
neighbors (Katchalsky and Spitnik 1947). Because slightly varying 
environments, each binding site exhibits a different dissociation constant pKa 
or pKb in the range of ~2 to ~10. It will be partially dissociated at intermediate 
pH. The apparent acidity of the weak polyacid decreases with progressive 
ionization of the polymer due to the difficulty deprotonation of the polymer 
chain (Burke and Barrett 2004). For a weak polyelectrolyte, an apparent 
equilibrium constant of acidity Kapp can be described in equation 2.2. 
       
        
  
   (Eq. 2.2) 
And the degree of dissociation α can be easily obtained by equation 2.3 
     
    
       
    (Eq. 2.3) 
As the pKa is defined as reflects the overall acid / base equilibrium of the 
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polyelectrolyte chains. Therefore, the acid / base equilibrium of the chains is 
defined by a modified version of the Henderson – Haselbalch equation. The 
equation takes the multifaceted dissociation behavior of polyion into account 
(n is depends on polymer charge density, which related to the extension of 
the chains):   
           
        
  
;              ,      
     ; 
                                
   
 
     (Eq. 2.4) 
The properties of both polymers and electrolytes are maintained in 
polyelectrolytes. It is difficult to predict their structure in aqueous media may 
be using theoretical models. Because of long chains of polymers can acquire 
a large number of different conformations, their shape and size can only be 
described statistically. Freely - jointed - chain model and the Gaussian model 
are two frequently used models to describe the average conformation of 
flexible neutral polymers in aqueous media. Both of the models consider the 
mean - squared end - to - end radius Ree (in equation 2.5) is proportional to 
the number of monomers N in the polymer chain multiplied by the effective 
monomer size   (H. Dautzenberg 1994):  
  𝑹 𝒆𝒆
𝟐  𝑵 𝟐   (Eq. 2.5) 
Because Ree is quite smaller compare with the length of the extended 
polymer, the above equation only presents uncharged polymers. The 
persistence length qp is used to present the stiffness and relative length of a 
charged polymer in solution. If the persistence length is longer than the 
polymer pieces, the molecule is similar as an elastic rod with more flexibility. 
If the persistence length is shorter, the molecule can only be described 
statistically, like a random walk in space. The persistence length of a 
polyelectrolyte is affected by the electrostatic interactions between monomer 
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and the counterions, and relate with the steric length q0 and the electrostatic 
contribution qe  
  𝒒   𝒒𝟎 + 𝒒𝒆   (Eq. 2.6) 
The qe is described as 




   
 𝒆  
 𝟐   (Eq. 2.7) 
  : Bjerrum length 
   : Debye length  
 𝒆   : Effective distance between charges. (Fleer 1993)  
Charges are electrically screened outside the Debye sphere with Debye 
length as radius. The Bjerrum length is the distance at which the magnitude 
of the electrostatic interaction between two elementary charges e is equal to 
the thermal energy (   ). 
      
𝒆𝟐
   𝟎 𝑹   
   (Eq. 2.8) 
  : Boltzmann constant 
 : Absolute temperature in Kelvin 
𝒆: Elementary charge  
 𝑹: Dielectric constant of the medium 
 𝟎: Vacuum permittivity  
For example two singly charged ions in water at room temperature using the 
equation 2.8,    is ~ 80, T is 300 K,      equal to 1 at the Bjerrum length, 
so    can be calculated as 0.7 nm. When the charge distance is smaller than 
the Bjerrum length, electrostatic counterions can lower charge density of 
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polyelectrolyte by condense on its chain. In an electrolyte solution or a 
colloidal dispersion, by measuring the Debye length express symbol     
(Russel, Russel et al. 1992) the impact of ionic strength I on the electrostatic 
persistence length is shown below: 
      √
 𝟎 𝑹   
𝟐𝑵 𝒆𝟐𝑰
   (Eq. 2.9) 
𝑵  is Avogadro’s number and the ionic strength 𝑰 is defined as: 




𝟐𝑪𝒊𝒊     (Eq. 2.10) 
𝒁𝒊: Charge valency 
𝑪𝒊: Molar concentration of the screening ions  
From the above equations, concentration of the screening ions is increased 
with Debye length and persistence length decreasing. The excess of 
electrolyte could make a coiled conformation easily when the conformation of 





2.2 Polyelectrolyte complexes 
Because of released counterions from the mixed solution of polyanions 
(├A- c+)n and polycations (├C
+ a-)m, interpolymer complexes (├A
- C+)x can be 
self-formed. Polyacids and polybases with their neutralized metal and 
halogenide salts are able to cause complex formation. The basic process (H. 
Dautzenberg 1994) is shown in Figure 2.1. 
 
Figure 2.1: Schematic diagrams of the release of counterions upon polyelectrolyte complex 
formation 
(├A- c+)n + (├C
+ a-)m ⇋ [(├A
- C+┤)x + (├A
- c+)n-x + (├C
+ a-)m-x] + xa
- +xc+ 
A- and C+ are polyelectrolytes charged groups; a- and c+ are counterions; n 
and m are number of anionic groups and cationic groups respectively. The 
degree of conversion θ (= 
 
 
 while n < m, or = 
 
 
 while n > m) gives the idea 
of the component ions are all formed by the oppositely charged groups or 
part of the counterions (Thünemann, Müller et al. 2004).  
The driving force of above process is gain in entropy due to release of low 
molecular counterions of a- and c+ which locate in the vicinity of the polyion 
chains. The main contribute to the complex formation is electrostatic 
interaction between the oppositely charged polyanions and polycations. 
Furthermore, the hydrogen bonding or hydrophobic interactions also play an 
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important role in complex formation. Michaels et al (Michaels and Miekka 
1961) defined a theory of polyelectrolyte complex formation with two 
structures. The complex formation defined as ladder models at the molecular 
level, and with large number of particles in a chain as scrambled egg models. 
Figure 2.2 shows the ladder and scrambled egg models. 
A) B)  
Figure 2.2: Images of the A) ladder and B) scrambled egg models.  
Models are based on the polyelectrolyte complex structure theory of Michaels and Miekka. 
(H. Dautzenberg 1994)  
The ladder like structure with fixed ionic crosslinks between two oppositely 
charged chains presents a complex reaction like a “zippering action”. Thus, 
the polyion close to the first reacted ones will be mostly reacted next. When 
the complex reaction is processing from more than one ions, a more cross 
linked structure is formed (Michaels 1965). Philipp et al (Philipp 1989) have 
been studied experimental structures between these two models. When the 
polyelectrolyte is close to another one, the restructuring complex is affected 
by the distance between charges, as well as the types of counterions present. 
The real structure of the complex is between the two models, but more 
favorite the scrambled egg structure with statistical charge compensation. 
  The polyelectrolyte structure formation mostly defined by the kinetics of 
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the process which usually less than 5 μs. Then, a slower step of chains 
redistribute to a conformation tend to equilibrium (Bakeev, Izumrudov et al. 
1992). Structure formation is influenced by other parameters have been 
discussed recently, such as mixing procedure, medium conditions include 
concentration of salt and polyelectrolyte, polymer chain flexibility, molecular 
weight and linear charge density (Dragan and Schwarz 2004; Thünemann, 
Müller et al. 2004). When prepare the polyelectrolytes complexes, small 
difference of used polyelectrolytes results big difference on restructured 
complexes. Basically, there are three types of polyelectrolytes complexes 
structure which are water soluble, colloidally stable, and coacervate 
complexes. Main interaction forces such as Coulomb forces, hydrogen 
bonding, hydrophobic interactions, van der Waals forces, and charge transfer 
interaction are used to classify these three types (Tsuchida 1982).  
2.2.1 Water-soluble polyelectrolyte complexes 
Under appropriate salt conditions, water soluble polyelectrolyte complexes 
are obtained by mixing polyions with significantly different molecular weight. 
For example, a high molecular weight polyion (longer chain) as host is mixed 
with an oppositely charged lower molecular weight polyion (small chain) as 
guest in non-stoichiometric proportions; or by reacting oppositely charged 
macro-ions of comparable chain length at extremely low concentrations 
(Kabanov 2003). The structure of this complex basically looks like the ladder 
model, contains hydrophilic single stranded and hydrophobic double 
stranded segments (Kabanov and Zezin 1984). Figure 2.3 shows a 




Figure 2.3: Image of a sequentially water-soluble polyelectrolyte complex. 
Water-soluble polyelectrolyte complex could rearrangements in medium 
with low salt concentration, and tend to the thermodynamic equilibrium. 
Polyelectrolyte charges are shield and the complexes are shrunk with more 
salt present. Precipitation can be seen with higher concentration of salt in the 
medium. If the amount of long polycations is bigger than the short polyanions 
in polyelectrolyte complex, they cover the hydrophobic part of the 
conformation. Otherwise, polyelectrolyte complex becomes a micelle like 
structure (Kiriy, Yu et al. 2006). 
2.2.2 Colloidally stable Polyelectrolyte complexes 
Strong polyelectrolytes re-formed polyelectrolyte complexes lead to a 
highly aggregated or macroscopic flocculated system (Thünemann, Müller et 
al. 2004). In a medium with very low concentration of polyelectrolytes, the 
aggregation is suspended with spherical structure (size up to 100 nm) at a 
colloidal level. Macroscopic flocculation of the system occurs usually with a 
ratio of 1:1 stoichiometry for strong polyelectrolytes. However, the 
stoichiometry is influenced by the flexibility of polymer.  
For instance, high stiffness polymer with non-uniform distribution in charge 
could leads to low capability of reconstruction. Thus, it tends to form 
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non-stoichiometric polyelectrolyte complexes. Moreover, branches of the 
polymer also make the reconstruction non-stoichiometric, due to the inner 
pieces of the molecules extremely hard to touch with the oppositely charged 
polyelectrolyte.  
Polyelectrolytes form denser structures cause stoichiometry approach 1:1 
ratio while adding salt to the medium (Vanerek and Van De Ven 2006). 
Complexation stoichiometry as a function of salt concentration has 
investigated many years before by Cundall et al (Cundall, Lawton et al. 1979). 
In pure water polyelectrolyte complexes formation is mostly affected by the 
kinetics during the complexes forming, result a frozen structures with 
non-thermo dynamic equilibrium.  
Polyelectrolyte complexes colloids are in a stable distribution with 
non-stoichiometric solution while its concentration is lower than 1 g/ml. Once 
colloids molar mass reduced, secondary aggregation starts. This happens 
while the molar mixing ratio closes to 1:1. Appropriate charge density in 
strong polyelectrolytes could result the colloidal particles seriously swelling 
due to unmatched charge densities (Thünemann, Müller et al. 2004).   
Salt significantly influences the polyelectrolyte complexes formation. 
Complexes are rapidly swelling or shrinking with varied ionic strength, but the 
coagulation speed is slower, depend on the colloidal particles concentrations 
(Dautzenberg and Rother 2004). During polyelectrolyte complexes 
conformation, the aggregation is suddenly reduced by adding salt. Higher 
ionic strengths lead to the secondary aggregation and macroscopic 
flocculation with the mixing ratios less than 1:1. It is caused by the screening 
of the electrostatically stabilizing shell of the major component around the 
polyelectrolyte complexes particles (Dautzenberg 1997).  
Furthermore, the univalence or divalent salt ions such as Li +, Na +, and K + 
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are all determine the interactions between the polyelectrolytes (Sukhishvili, 
Kharlampieva et al. 2006). 
2.2.3 Coacervate Polyelectrolyte complexes 
Oppositely charged polyelectrolytes are entangled with low charge density 
to form the coacervate complexes. It has the feature of liquid-like, 
electrophoretic mobility, and the structure reversibility (Biesheuvel and Stuart 
2004a).  
 
Figure 2.4: Schematic illustration of the effect of molecular weight on the formation of 
colloidal and coacervate complexes.  
Low molar mass cPAM forms primary colloidal complexes while high molar mass cPAM 
forms mostly coacervate complexes with sulfonated kraft lignin (SKL) (Vanerek and Van De 
Ven 2006). 
Figure 2.4 shows the effect of molecular weight on the formation of 
colloidal and coacervate complexes. Because the short chain is more favor to 
a precipitate coiled conformation, lower molecular weight of the mixed 
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polyelectrolytes is the main factor. Water soluble, colloid and coacervate of 
polyelectrolytes complexes are able to be formed at the same time. 
Biesheuvel et al design a mathematical model to investigate formation of 
coacervate complexes with different electrostatic free energy. In the model, 
several parameters such as distance between charges, salt concentrations 
and molar mixing ratios can be modified to determine the form of coacervate 




2.3 Polyelectrolyte Multilayers 
Absorption of polyelectrolytes at surfaces is affected by many parameters, 
such as the polymers charge density, molecular weight and conformation. 
Moreover, other factors also influence the interface of polyelectrolytes 
absorption, like solvent’s pH value, and ionic strength. More details will 
discuss in the following sections. 
2.3.1 Polyelectrolyte absorption on a solid surface 
The absorption of polyelectrolytes at interfaces is more like complex 
formation. The film structure fabricated by the absorption is mostly affected 
by the polyelectrolytes structure and the ionic strength. For polyelectrolyte 
with a non-twisted structure, the thin film is more easily deposited with low ion 
concentration. In this condition, nearly all charges of the polyelectrolyte are 
combined with the opposite ones at the surface along the polymer chains. 
Otherwise, polyelectrolyte with twisted structure is difficult to deposit entire 
pieces on the template surface. Therefore, the structure contains absorbed 
polymer chain called trains and non-absorbed chains like loops, and tails are 
shown in Figure 2.5.  
Meaning of Tails and loops of the polymer chains just like their names. 
Tails are the end section of the polymer, and loops are parts of polymer chain 
which are not on the substrate surface. The main reason for forming the tails 
and loops structure is re-conformation speed of the coiled polymer much 
slower than the absorption speed on the substrate surface. Furthermore, 
electrostatic repulsion and steric effects prefer to attract only some part of the 




Figure 2.5: Schematic illustration of polyelectrolyte’s absorption at an oppositely charged 
surface. 
Polyelectrolytes are in a rod-like formation (top) and in a coiled conformation (bottom). After 
the deposition, polymer sections of loops and tails are not blinding on the substrate surface 
lead to charge overcompensation.  
Beltran et al discovered that tails are favored at low degrees of chain 
ionization, while trains prefer high degrees of ionization. The number of 
adsorbed chain sections is increased with increasing charge density of 
surface and decreasing ionic strength in solution (Beltran, Hooper et al. 1991). 
As deposited film is formed by great numbers of polymers, the tail structure 
could also occur when one polymer is mostly absorbed, but the area of 
substrate surface for end of the polymer is already taken by the next polymer 
chain.  
Because tails and loops exist in the deposited polyelectrolyte on the 
substrate surface, the charge of the polymer film is opposite to the substrate. 
It is called “charge overcompensation” which is the primary condition to make 
multilayer systems using the Layer-by-Layer technique.  
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2.3.2 The Layer-by-Layer technique 
In the 1990s, Decher and Hong used complex formation of polyionic and 
polycationic compounds to produce organized multilayered thin films (Decher 
and Hong 1991a; Decher and Hong 1991b; Decher, Hong et al. 1992). This 
electrostatic layer-by-layer (LbL) assembly has been first investigated by Iler 
(Iler 1966). In the experiment, charged solid substrate is added into aqueous 
solutions of polyelectrolyte with positive charge and followed negative charge. 
For each layer of absorption, the polyelectrolyte molecules are attracted by 
the oppositely charged surface until fully covered film formed.  
In the process of film forming, entropically driven by the release of 
counterions, restrict by electrostatic repulsions. Followed by the surface 
saturation, and then solid substrate is washed to remove the uncoated 
polymer that suspended in the solution. During LbL assembling, each 
adsorption step reverses the surface charge. So far, no number of layers is 
limited with this technique, Lenahan et al successfully fabricated a number of 
1000 layers film (Lenahan, Wang et al. 1998).  
Figure 2.6 shows a typical LbL process: a substrate with positive charge on 
the surface is immersed into a polyelectrolyte solution contains polyanions 
and appropriate concentration of salt. Salt helps polymers form a coiled 
structure. The polyelectrolytes distribute in the solution, some of them close 





Figure 2.6: The electrostatic layer-by-layer (LbL) assembly.  
(A) The mainly methods in experiment. (B) Theory explanation (Decher 1997). 
After a certain time, most charges of the polymer chain are paired with the 
charges on the substrate. Thus, a layer of polyelectrolyte is formed on the 
substrate with a stretched conformation. Because loops and tails structures 
of polymer exist in the layer, charge overcompensation is approached. Then, 
the substrate with negative charge at the outmost layer is washed with water 
to remove excess polymer. The following layer is coated by immerse the 
substrate into polyelectrolyte solution with polycations and salt. After these 
steps, the thermodynamically stable polyelectrolyte bilayer is constructed on 
the substrate.  
The process of a template with the polyanions /wash /polycations /wash 
steps could be repeated many times until a desired number of layers are 
coated. The thickness of one layer is from several angstroms to few 
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nanometers depends on the deposition conditions. Therefore, thickness of 
the film is able to be varied with an exactly numbers in the angstrom range. 
Under the LbL technique, multilayers on macroscopic substrates are able to 
be fabricated by spraying (Schlenoff, Dubas et al. 2000; Izquierdo, Ono et al. 
2005) or spin coating (Chiarelli, Johal et al. 2001) which reduces the 
preparation time significantly. 
LbL technique based on electrostatic interactions between oppositely 
charged polyelectrolyte is variety used for polyelectrolyte complex fabrication. 
The multilayer films are able to be assembled by differently functionalized 
synthetic polyelectrolytes (Baur, Kim et al. 1998; Jaber and Schlenoff 2005); 
charged biopolymers such as proteins (Lvov, Ariga et al. 1994; Lvov, Ariga et 
al. 1995; Onda, Lvov et al. 1996; Caruso, Furlong et al. 1998); nucleic acids 
(Lvov, Decher et al. 1993; Sukhorukov, Möhwald et al. 1996); lipids 
(Georgieva, Moya et al. 2000; Tiourina, Radtchenko et al. 2002); 
bolaamphiphiles (Saremi, Maassen et al. 1995; Saremi, Tieke et al. 1997; 
Dreja, Kim et al. 2000; Jung, Hong et al. 2002); viruses (Lvov, Ariga et al. 
1994); metallo-supra molecular polyelectrolytes (Kurth, Schütte et al. 2002); 
inorganic nanoparticles like gold colloids (Cant, Critchley et al. 2003); 
quantum dots (Gao, Lesser et al. 2000); fullerenes (Guldi, Luo et al. 2002); 
carbon nanotubes (Mamedov, Kotov et al. 2002; Rouse and Lillehei 2003); 
dendrimers (Kim and Bruening 2003; Li, Mitamura et al. 2003); and 
multivalent organic ions such as dyes (Ariga, Lvov et al. 1997; Laschewsky, 
Wischerhoff et al. 1997).  
This multi-function allows the high speed and uncomplicated preparation of 
surface covered layer depositing or free standing thin films with many 
properties, such as chemical, biological, optical, electronic, magnetic, 
anti-bacterial, or perm-selective, which make the applications suitable in a 
widely filed (Bertrand, Jonas et al. 2000).  
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2.3.3 Stabilizing interactions within multilayers  
The driving force for polyelectrolyte layer deposition is electrostatic 
interactions, and the layer thickness is affected by the electrostatic repulsions 
of polyelectrolytes charge. Polyelectrolytes need have a minimum charge 
density for attracting with the charged surface of substrate (Steitz, Jaeger et 
al. 2001). Schoeler et al found a special case that a polyelectrolytes 
deposition has been discovered below the minimum charge density 
(Schoeler, Poptoshev et al. 2003), and propose the strength of the 
electrostatic interaction is more important than the charge density limitation.  
The ions exist in the polymer solution is required to reach the charge 
overcompensation for depositing the following layer. After each 
polyelectrolytes deposition step, several times of wash step is used to 
remove the uncoated polymer. This step also washes the ions which 
connected with the polyion of the coated layer. Thus, high electrostatic 
interactions in a high compact layer lead to multilayers swelling (Sukhorukov, 
Schmitt et al. 1996).  
The layers keep stable with enough number of polyion pairs exist. But high 
concentration of salt presents in the solution is able to cause the over 
screening within the layers, and disassemble the film. The ionic strength 
influences polyelectrolyte ion pairs of the film under the following equation. It 
shows the polyion pairs in an electrostatic bond with added ions a + and b - in 
the solution (Dubas and Schlenoff 2001). 
(├ A+ B- ┤)n + na
+ + nb- ⇋ (├ A+ b- )n + (a
+ B- ┤)n 
Electrostatic interactions are reduced as high salt concentration present, 
result the polyion abandon thermodynamically favored conformation and 
back to the bulk solution. Thus, the electrostatic contribution is a very 
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important parameter of film stability. Besides electrostatic, other weak 
interactions are also contribute to a successful LbL deposition, for example 
hydrogen bonding (Stockton and Rubner 1997; Pontes, Raposo et al. 1999); 
hydrophobic interactions between polyelectrolytes (Dubas and Schlenoff 
1999); charge transfer and π-π stacking, Van der Waals interactions (Kotov 
1999); even polyelectrolyte with same charge, the hydrogen bonding formed 
multilayers could also be possible (Wang, Wang et al. 1997). 
2.3.4 Growth and structure 
When construct the multilayers, different polyelectrolytes result different 
thickness increments after every layer. For strong polyelectrolytes formed 
films, the thickness is more linearly as the number of layers increasing, and 
the mass of each polyelectrolyte layer is almost same (Ruths, Essler et al. 
2000; McAloney, Sinyor et al. 2001). Some weak polyelectrolytes show an 
exponential increase on mass with the number of film layer increasing. The 
reason is one of used polyelectrolyte diffuse through the film raising the mass 
of last deposited layer (Picart, Lavalle et al. 2001; Lavalle, Picart et al. 2004).  
Ladam et al (Ladam, Schaad et al. 2000) proposed a zone model for the 
multilayer film structure. The model can be divided into three zones named 
zone 1, 2 and 3 with defined properties respectively. Figure 2.7 shows zone 
model of the growth of polyelectrolyte multilayers. In zone 1, the first 
polyelectrolyte layer contact with the substrate. Conformation of the layer is 
directly determined by the solid support, and thickness of the layer usually 
less than the following layer in Zone 2. Zone 2 refers to the internal part of the 
film that between Zone 1 and 3. Therefore, Zone 2 determines most 
permeability and mechanical stability of LbL films. Polymer layer in Zone 3 
exposes to the solution and contains excess charge is the last layer covers 
the multilayers (R. v. Klitzing 2002). Furthermore, Zone 3 more likes the 
diffusion depth is called a penetration length, through which polyion can pass 
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Zone 3 and spread to the layers of above zones (Schlenoff and Dubas 2001; 
Salomäki, Vinokurov et al. 2005; Porcel, Lavalle et al. 2006). 
At the beginning of multilayer fabrication, only Zone 1 and 3 present in the 
film. As the deposition continues, the layers thickness is increasing, so Zone 
2 is growing. In this LbL assembling, every layer will switch the transition area 
between Zone 2 and Zone 3. Thicknesses of the first and last layer are 
mostly determined by the used polyelectrolyte pair and the deposition 
conditions.  
 
Figure 2.7: Zone model shows the growth of polyelectrolyte multilayers.  
From left to right, shows the progressive evolution of the three different zones, and on the 
right a concentration profile for a multilayer composed of 10 layers shows the strong overlap 
between adjacent layers (Decher and Schlenoff 2003) 
The growth of first layer in Zone 1 is mostly affected by the substrate 
surface. Thickness and mass growth of other layers with layer number 
increasing can be divided as exponential and linear growth. In exponential 
growth case, penetration depth is increased with thickness of Zone 3 
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increasing. Polymers penetrate Zone 3 and deposit in Zone 2 until the 
polyions are no longer diffuse through the diffusion depth. At this point, the 
Zone 3 reaches a critical thickness and Zone 2 stop growing. If the 
penetration depth of Zone 3 is fixed, the amount of polymer deposit every two 
layers is constant, which change the exponential growth to linear type. 
In case of polyelectrolytes Poly (Allylamine Hydrochloride) (PAH) and Poly 
(Styrene Sulfonate) (PSS) formed pairs in a low ionic strength solution at 
room temperature; Zone 3 is a linear growth after the first deposited layer of 
Zone 1. For some polyelectrolyte such as poly (L-lysine) and hyaluronic acid, 
the polyions are able to penetrate deeply into the Zone 2 layer, cause the 
linear growth only be discovered after 25 or even more layers deposited (P. 
Lavalle 2004).  
Moreover, the growth of polyelectrolyte multilayer is influenced by many 
parameters, for instance: ionic strength, polymer concentration (Lösche, 
Schmitt et al. 1998; Dubas and Schlenoff 1999; Steitz, Leiner et al. 2000; 
Steitz, Jaeger et al. 2001); charge density of the polymer (Glinel, Moussa et 
al. 2002; Schoeler, Kumaraswamy et al. 2002); molecular weight of the 
polyion (Dubas and Schlenoff 2001; Sui, Salloum et al. 2003); different kinds 
of salt in solution (Salomäki, Tervasmäki et al. 2004); different pH value 
(Shiratori and Rubner 2000; Choi and Rubner 2005); different solvent 
(Poptoshev, Schoeler et al. 2004); temperature (Tan, Meredith et al. 2003; 
Poptoshev, Schoeler et al. 2004; Gopinadhan, Ahrens et al. 2005) and time 
for deposition (Lvov, Decher et al. 1993). In conclusion, the ionic strength and 
temperature increased result formed film thickness increasing and 
exponential growth area prolonging. 
In Zone 2, counterions density of polymer layers is less than polyion 
monomer density. Because present charged polyelectrolyte parts are paired 
by oppositely charged polyion parts (Klitzing and Moehwald 1995; Schlenoff, 
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Ly et al. 1998). Reconstruction of polymer chains is blocked by multiple ionic 
bonds as the polymers are firmly combined with each other. Because the 
charge overcompensation, polymer contains many counterions in Zone 3, 
and less densely formed than the polymer in Zone 2. Thus, the inside of 
polymer multilayers even has hydrophobic property may contains fifty percent 
of water (Estrela-Lopis, Leporatti et al. 2002); and ten to twenty percent of 
water been detected in dried state of the film (Farhat, Yassin et al. 1999).  
The permeability of the multilayers for small molecules has been well 
known (Klitzing and Möhwald 1996; Regine v. Klitzing* and Möhwald 1996), 
which is determined by the film thickness, different types of the deposition 
polyelectrolytes and the solvent conditions. Moreover, the film with bipolar 
conformation has a property of selective differently charged ions or polar and 
non-polar compounds. Thus, the multilayers film attractive as separation 
membranes for ions, gases, and solutes (Krasemann and Tieke 1999; 
Krasemann and Tieke 2000; Krasemann and Tieke 2000; v. Klitzing and 
Tieke 2004; Jin, Toutianoush et al. 2005).  
2.3.5 Stimuli-responsive properties of supported multilayers 
The growth of polyelectrolyte multilayers is affected by many parameters, 
the films after deposition are also influenced by in the environment changes, 
for example: humidity (Kügler, Schmitt et al. 2002; Wong, Rehfeldt et al. 
2004); solvent (Müller, Heinen et al. 2001); pH (Hiller and Rubner 2003; Zhai, 
Nolte et al. 2004); ionic strength (Dubas and Schlenoff 2001; McAloney, 
Dudnik et al. 2003) and temperature (Steitz, Leiner et al. 2002). Moreover, 
the dried multilayers films swell in water, or in a humidity environment, and 
become three times larger than the original thickness (Ahrens, Büscher et al. 
2004). Figure 2.8 shows the changed temperature affects capsules shrinking 
and swelling. If the multilayers film contains one weak polyion, it only affected 
by changed pH value. Therefore, the charge balance in the multilayer varies 
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due to additional acid or base, and result a network re-conformation. Except 
continuous or discontinuous transitions of swelling and shrinking, wetness 
and roughness of the film surface changes; morphology and porosity of the 
multilayer have been investigated (Yoo, Shiratori et al. 1998; Mendelsohn, 
Barrett et al. 2000; Hiller, Mendelsohn et al. 2002). 






Figure 2.8: SEM micrographs of capsules shrinking and swelling. 
Top images are initial capsules, bottom capsules are treated with heating. Thermally shrunk 
of (PDADMAC/PSS)4 capsules (left) and thermally swollen of (PDADMAC/PSS)4PDADMAC 
capsules (right). (Köhler 2006) 
Because the multilayers films are formed mostly by the electrostatic 
interactions, the ionic strength of the solution is more important to its 
conformation. Salt ions could increase the re-conformation of the polyion due 
to screening of the charges which result the polymer chains become smooth 
and inter-diffusion (McAloney, Dudnik et al. 2003). The conformation is also 
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determined by the salt type, the polyion bonding strength and the interactions, 
for instance hydrophobic and ionic strength lead to the beginning of the 
reconstruction (Dubas and Schlenoff 2001). Typically, the multilayers films 
swell with additional salt present, but for some polyelectrolyte film such as 
PSS/PDADMAC shows shrinkage and decomposition while a strong ionic 
strength exist. For study of multilayers affected by temperature change, many 
groups focus on the temperature response of the thermo sensitive films, only 
few experiments about no functionalized multilayers such as PAH/PSS film 





2.4 Polyelectrolyte multilayer capsules 
  Multilayer films are made from sequentially absorb the oppositely 
charged polyelectrolytes on a substrate surface, and this method was first 
reported by Iler (Iler 1966). Decher et al investigated a self-assembly process 
using electrostatic interaction (Decher and Hong 1991a). Multilayer films are 
fabricated from electrostatic self-assembly method are suitable for most of 
charged substrate and better than other well established deposition 
techniques. At the interface of the substrate and polymer, the driving force of 
electrostatic interaction makes an excessed surface charge also called 
charge overcompensation. Electrostatic self-assembly technique could also 
produce multilayer films on a substrate with a non-flat surface known as 
Layer-by-Layer (LbL) technique (Sukhorukov, Donath et al. 1998).  
The particle template in a micron size with a porosity property can be 
coated with multilayer films using LbL technique. If the polyelectrolyte film is 
stable after fabrication and even after template dissolution, the free standing 
membrane formed capsule with inside hollow structure is obtained (Donath, 
Sukhorukov et al. 1998; Sukhorukov, Donath et al. 1998). Polymer 
microcapsules preparation and fabrication, also substances encapsulation 
have been investigated many years before (Chang 1964).  
Polyelectrolyte microcapsules under LbL process are much better than 
other micro containers such as micelles, liposomes, inorganic hollow shells. 
Especially in capsules mechanical properties with various factors changed on 
the multilayered films, for example: the layers composition, thickness, 




2.4.1 Polyelectrolyte multilayer capsules preparation 
In 1998, hollow capsules on colloidal particles with non-planar surfaces 
was successfully formed by LbL assembly (Sukhorukov, Donath et al. 1998).  
Therefore, a charged surface is the only required condition for a substrate as 
template for capsules preparation, any shapes, morphology and composition 
are not problems. Some parameters of the solution have to be modified to a 
certain value, such as pH, ionic strength and polyion concentration. 




Figure 2.9: Substance encapsulation and hollow microcapsule fabrication. 
Substance is mixed (A) and co-precipitated (B) with CaCO3, and then covered by oppositely 
charged polyelectrolytes (C). Hollow capsules are obtained after core dissolution (D) (De 
Koker, Naessens et al. 2010). 
Figure 2.9 shows general encapsulation of substance and fabrication of 
hollow microcapsule. After the required number of layers is coated, the 
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templates used for multilayers films deposition are dissolved. Two main 
conditions are required in dissolution step. One is polymer complexes remain 
stable during templates removing, and another one is most of the 
decomposed templates can pass the semipermeable shell. After all, the free 
standing multilayer films constructed hollow polymer shells are produced. 
Microcapsules are conformed in aqueous media under the self-assembly 
process. After each deposition step, centrifugation step is used to separate 
the colloid templates from the supernatant (Sukhorukov, Donath et al. 1998); 
or a micro filtration is using for supernatant removing (Voigt, Lichtenfeld et al. 
1999). Plenty of washing is important to remove loosely bond and uncoated 
polyelectrolytes. This step prevents polyelectrolytes complexes constructing 
in the solution without template and cause the solution milky-like and 
impurity.  
The exact amount of polyelectrolyte needed to fully cover the template 
surface can be calculated theoretically assuming flat surface of template. 
Otherwise, the surface area is not possible to calculate for colloid particles in 
suspended solution. Thus, the overdose of polyelectrolyte solution should be 
added for each polymer layer coating (Peyratout and Dähne 2004). LbL 
process has been used to produce capsules size ranging from 15 nm 
(Schneider and Decher 2004) to 20 μm (Shenoy, Antipov et al. 2003).  
Generally, shell component materials to form polymer microcapsules are 
required to containing minimum one polyion. Any charged polymer can meet 
the requirement, no matter synthetic polyelectrolytes or biomolecules. Small 
or low charge density molecules pair with oppositely charged polyions is 
easily neutralizing the surface charge, not reversing the charge. Thus, the 
following layer cannot be coated, and using these molecules for multilayer 
films self-assembling is difficult. But chemical cross‐linking (Tong, Gao et al. 
2005; De Geest, McShane et al. 2008; Wang, Bansal et al. 2008) and click 
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chemistry (De Geest, Van Camp et al. 2008; Connal, Kinnane et al. 2009) 
have been reported recently, which successfully use small molecules or 
same charge materials to form multilayer complexes. 
2.4.2 Template core dissolution 
Many different types of template have been used for fabricating 
polyelectrolyte microcapsules, such as solid particles, liquid droplets and 
micro bubbles (Shchukin, Köhler et al. 2005; Fernandes, Tzvetkov et al. 2008; 
Gedanken 2008). But the liquid droplets and micro bubbles as the template 
core are not stable during the LbL process. Therefore, we focus on the 
template of solid particle. There are variety types of solid templates, such as 
organic particles like latexes (Sukhorukov, Shchukin et al. 2004); gel beads 
(Shenoy and Sukhorukov 2005; De Geest, Dejugnat et al. 2006); inorganic 
particles with size from nanometer to microns like silica (  dard,  raun et al. 
2008; Bedard, Munoz-Javier et al. 2009) and calcium carbonate (Sukhorukov, 
Volodkin et al. 2004; Volodkin, Larionova et al. 2004; Volodkin, Petrov et al. 
2004); also living cells (Moya, Dähne et al. 2001; Neu, Voigt et al. 2001).  
Microcapsules can be produced with size ranging from nanometers to 
microns. The limitation of the capsules minimum diameter is the stability 
decrease of depositing polymers on small particles cores. Maximum diameter 
of capsule is limited by osmotic pressure that leads to the large core particles 





Figure 2.10: SEM images of the melamine formaldehyde microspheres prepared at pH=6.0. 
(Cheong, Shin et al. 2004) 
Melamine formaldehyde (MF) micro particles (Figure 2.10) with properties 
of mono disperse and weakly cross-link has been mostly used as template 
core for capsule fabrication. MF particles are easily and quickly decomposed 
by acidic hydrolysis with HCl in a less than 1.6 pH value or some polar 
solvents like N,N-Dimethylformamide (DMF). The molecular weights of MF 
oligomers in the region from 4 to 14 kDa are not easy decomposed. Because 
decomposed MF particles pass the polymer shell is slower than the speed of 
MF particles reforming. Thus, capsules can be damaged or even ruptured 
during MF decomposition step (Gao, Moya et al. 2001). Moreover, the 
un-dissolved MF template and residual decomposed particles still leave 
inside the capsules or remain in the shell, which may cause the capsules 




Figure 2.11: SEM images of PS particles prepared by surfactant-free emulsion 
polymerization. 
(Telford, Pham et al. 2013)  
Polystyrene (PS) (Figure 2.11) and poly (lactic acid) (PLA) are soluble in 
organic solvent, and are used extensively. But the completely removal of the 
PLA template is difficult and some residual of the decomposed PLA may 
remain inside capsules (Déjugnat and Sukhorukov 2004). Because the 
polymer films are in a glassy state, the morphology of capsules produce from 
LbL technique is mostly depends on the template core. Thus, to determine 
which type of cores is used for encapsulation is important. 
Compared with organic template, inorganic cores can be completely 
decomposed and removed from capsules, such as manganese carbonate, 
silicon oxide, cadmium carbonate and calcium carbonate can be dissolved 
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into low molecular weight ions and carbon dioxide (Antipov, Shchukin et al. 
2003). Thus, the decomposed cores are able to pass the polymer multilayer 
shell easily. Carbonate cores are able to be dissolved under a slightly acidic 
conditions or in ethylenediaminetetraacetic acid (EDTA) solution (Borodina, 
Markvicheva et al. 2007). Furthermore, due to the porosity of calcium 
carbonate, the polyelectrolytes could penetrate core surface in deposition 
step which lead to a complex network constructing of capsules interior 
(Volodkin, Petrov et al. 2004).   
Compare with carbonate templates, silicon oxide has more smooth surface 
and spherical shape, but these particles are dissolved in hazardous and 
aggressive solutions such as ammonium fluoride (NH4F) or hydrogen fluoride 
(HF). These solvents are able to make the capsules aggregation, specially for 
the weak polyelectrolytes capsules (Adalsteinsson, Dong et al. 2004; Itoh, 
Matsusaki et al. 2004). Mono-dispersed gold particles with nanometers size 
have to be dissolved in a more dangerous solution of potassium cyanide 
(KCN) (Schneider and Decher 2004). Because inorganic templates can be 
completely removed and only few or no influence on polymer multilayer films 
structure, they are preferred template and well used for microcapsules 
preparation. 
2.4.3 Stimulus-free encapsulation and release methods 
Polyelectrolyte microcapsules have ability of trapping substances in the 
capsules cavity performs important property for its applications. Therefore, a 
large number of encapsulation methods have been studied. The desired 
materials with low solubility can be coated by polyelectrolyte for controlled 
and released. The disadvantage of this method is require the materials have 
appropriate sizes and shapes like crystals, particles aggregated or in 
nano-size (Lu, Möhwald et al. 2007; Prouty, Lu et al. 2007). Two typical 
methods are well used for substance encapsulation. One is combining the 
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desired substance with the template before polyelectrolyte deposition step, 
and another one is diffusing the substance through the microcapsules shell 
after hollow capsules fabrication. 
Substances are encapsulated with carbonated particles template before 
capsules fabrication. The desired substance are pre-mixed with the chemical 
solution and then forming the template particles (Petrov, Volodkin et al. 2005; 
Borodina, Markvicheva et al. 2007); or immersing the template particles into 
the substance solution which is diffusing into carbonate porous structure 
(Sukhorukov, Volodkin et al. 2004).  
 
Figure 2.12: SEM images of CaCO3 particles.  
(A) overview of CaCO3 particles and (B) porosity of CaCO3 (Volodkin, Petrov et al. 2004) 
Calcium carbonate particles as template are suitable for both pre- and 
after-loading encapsulation methods. After core dissolution the desired 
substance are encapsulated within the hollow polyelectrolyte microcapsules. 
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For size of desired substance is too big to pass through the polymer 
multilayers shell, or substance is affected by the conditions during LbL 
assembly process, the pre-loading method is better than after-loading 
method. (Kreft, Javier et al. 2007). An SEM image of CaCO3 particles with a 
size of ~ 4 μm is shown in Figure 2.12 and the pores are clearly visible in the 
high magnification image.  
Recently Kreft et al use this co-precipitation method to fabricate capsule in 
capsule, and each capsule contains different substance. The first desired 
material α is co-precipitated with CaCO3 and absorbs a polymer layer shell. 
Then these capsules contain material α are co-precipitated with larger 
CaCO3 particles with the second desired material β solution. Then, capsules 
are produced using LbL process (Kreft, Skirtach et al. 2007). EDTA is added 
to dissolve all CaCO3 template cores, thus shell in shell microcapsules 
contains material β with an inside capsule contains material α are obtained.  
Encapsulated substance releasing, capsules deformation and mechanical 
properties of capsules have been investigated (Cordeiro, Coelho et al. 2004). 
Atomic Force Microscope (AFM) is used for microcapsules shear stress and 
compression test (Lulevich, Radtchenko et al. 2003). Furthermore, certain 
enzymes change the permeability or degrade the shell of biological 
polyelectrolyte capsules, so the encapsulated materials are released (Kreft, 
Skirtach et al. 2007). Small molecules substance have also been studied by 
labeling on other materials and then encapsulated method (Gao, Donath et al. 
2002). 
2.4.4 Nanoparticles functionalized capsules 
  This part describes attachment of functionalized nanoparticles to the 
growth of multilayer films forming polyelectrolyte / nanoparticle layer. The 
formation of multilayer films depends on electrostatic interactions between 
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alternate layers of opposite charge. It was first introduced by Iler (Iler 1966) 
and developed by Decher (Decher and Schlenoff 2003). The composition of 
capsule shells can be tailored with metal nanoparticles. Therefore, these 
capsules are potential delivery vesicles in drug delivery system (Skirtach, 
Dejugnat et al. 2005). 
2.4.4.1 Magnetite nanoparticles 
Metal and metal oxide nanoparticles lead themselves to a variety of 
applications to the formation of polymer / nanoparticles composite films. 
Magnetite nanoparticles have small sizes varying from few nanometers to 
tens of nanometers. Property of magnetite nanoparticles obey Coulomb’s law 
is very interesting. Therefore, an external magnetic field gradient is able to 
manipulate these particles. Furthermore, delivery substances or drugs with 
these particles are able to target a desired region.  
 
Figure 2.13: Images of capsules with magnetite nanoparticles.  
SEM (left) and TEM (right) images show capsules with magnetite nanoparticles (Zhang, 
Zhou et al. 2013). 
Figure 2.13 shows magnetic chitosan / poly (N-isopropylacrylamide) 
microcapsules. Magnetite nanoparticles are resonantly responding to a 
magnetic field, and absorb energy from the exciting field. (Pankhurst, 
Connolly et al. 2003). With magnetite nanoparticles, the drug is able to be 
 53 
 
transferred to a targeted region under an external magnetic field and the 
release rate of the drug can be controlled under an external environment. 
2.4.4.2 Gold colloid nanoparticles 
Same as magnetite nanoparticles, Gold colloid Nanoparticles (GNP) can 
be incorporated with capsules shell by electrostatic interactions. Images of 
GNPs incorporated microcapsules are shown in Figure 2.14. These gold 
nanoparticles labeled capsules are sensitive to high temperature. Therefore, 
GNPs are used as trigger for encapsulated substance releasing near infrared 
in biomedical applications (  dard,  raun et al. 2008). Better than visible or 
UV light, near infrared is able to penetrate deeper in living tissues. Remotely 
release the encapsulated substance at desired region is important in drug 
delivery.  
 
Figure 2.14: Images of GNPs incorporated capsules. 
(a) SEM and (b) TEM images of (PAH/PSS) microcapsules contain GNPs in the shell. 10 nm 
non-aggregated gold nanoparticles and 20 to 50 nm gold sulfide core / gold shell 
nanoparticles can be seen in image b). (Skirtach, Dejugnat et al. 2005) 
Gorin et al have fabricated biocompatible capsules with both magnetite 
and gold nanoparticles. These capsules are optically addressable and 
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susceptible to magnetic field (Gorin, Portnov et al. 2008). Moreover, GNPs 
always accompanied with stimulus responsive release method. 
2.4.5 Stimulus-responsive encapsulation and release methods 
Targeted delivery and controlled release of microcapsules contain desired 
substance play a very important role in investigation of microcapsules field. 
Most small ions as well as water molecules can easily pass the 
semi-permeable shell of the capsules (Klitzing and Moehwald 1995), but 
larger molecules are too big to pass the smaller pore size (Dong, Ferri et al. 
2005). It depends on deposited polyelectrolyte, the conditions of the coating 
solution, the thickness of the shell and the template core used for capsule 
fabrication (Antipov, Sukhorukov et al. 2002).  
 
Figure 2.15: Schematic illustration of the laser induced opening of a capsule at a desired 
area.  
(Bedard, De Geest et al. 2009) 
For this encapsulation method, the release of the materials inside the 
microcapsule always accompanied triggers (De Geest, Sanders et al. 2007). 
Proximal and external are two types of triggers. Proximal trigger has to work 
within the solvent or present an interaction with the capsules such as 
appropriate pH, temperature and ionic strength (Gao, Leporatti et al. 2003; 
Déjugnat and Sukhorukov 2004; Georgieva, Dimova et al. 2005). External 
trigger directly works on the capsules with few or no influence on the solution, 
such as radiation, light, ultrasound, magnetic field and microwaves(Dalecki 
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2004; Kreft, Skirtach et al. 2007; Skirtach, Karageorgiev et al. 2008; Pavlov, 
Saez et al. 2011). Therefore, polyelectrolyte microcapsules are able to be 
remotely opened by these triggers to release encapsulated substances are 
very attractive for in vitro and in vivo experiments in drug delivery system.  
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2.5 Epithelial cells 
Epithelial cells are firmly bounded cell layers cover internal and external 
surfaces of organs, also the primary component in human skin. These cells 
are very densely packed together without hardly any intercellular space. 
Epithelial cells are able to construct continuous layers that are connected the 
neighbors at many locations through several types of interactions, such as 
adherens junctions, tight junctions and desmosomes (Marieb and Hoehn 
2007). Epithelial cells play a very important role at interfaces between the 
internal and external environments of the body. Because substances going in 
and out of the body have to pass through epithelium, the epithelial cells form 
an excellent biological barrier for drug delivery is of great interest to 
scientists.   
2.5.1 Structure of epithelial cell 
Figure 2.16 shows components of epithelial cells and characteristics of 
epithelial cell junctions. Epithelial cells are polarized and exhibit specific 
domains which are apical region, lateral region and basal region.  
Apical region locates at the top of epithelial cell and faces the lumen or 
outside of the organ. Thus, apical region is also named free surfaces due to 
no connections between it and other cells or tissues. The free surfaces are 
the interface between epithelial cells and external environment. Apical region 
contains microvilli, cilia and the glycocalyx. Microvilli are tiny brush like 
plasma membrane evaginations of the apical surface. It significantly 
increased the absorptive capacity of epithelial cells. Cilia are also plasma 
membrane and locate in the tips of apical surface similar as microvilli. 





Figure 2.16: Characteristics of epithelial cell junctions. 
Lateral region is most important functional surface in epithelial cells. It 
facing and connecting neighboring epithelial cells by junctional complexes. 
The lateral surfaces are the interfaces between epithelial cells, and contain 
tight junctions, adhering junctions, desmosome and gap junctions.  
Tight junction is closest junctions in epithelium locates just beneath the 
apical surface, and firmly associates cells membrane and forms almost 
impermeable barrier to fluid. Thus, substances enter or exit the epithelial 
layer have to penetrate the cell membranes not the intercellular gaps 
between cells. Adhering junction is belt like junctions at the top of epithelial 
cells locates below tight junctions. There is a 15 to 20 nm wide space 
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between adjacent cell membranes. Desmosomes have elliptical shape 
construct spot like adhesions of attachment between cells lateral sides of 
plasma membranes. The intercellular space is up to 30 nm wide. A huge 
amount of desmosomes exist in stratified squamous epithelial cells. Gap 
junction (also named nexus) is a junctional area between adjacent cells and 
permits intercellular passage of ions, amino acids, and other small molecules. 
(William and Krause 2005) 
Basal region locates at bottom of epithelial cells, faces the basal lamina 
adjacent to underlying connective tissue and blood vessels. Basement 
membrane is a thin layer supports epithelial cell, and formed by basal lamina 
and the reticular lamina. Basal lamina is an extracellular matrix layer 
produced by epithelial cell. The reticular lamina is formed by reticular fibers 
produced by the underlying connective tissues, and linked with Basal lamina 
by anchoring fibrils. Moreover, the nucleus of the epithelial cell is located 
around the basal region not the apical region. 
2.5.2 Classification of epithelial cells 
Glandular or lining are the two types of epithelium. Glandular epithelial 
cells adapted specifically for secretion constitute the glands. Lining epithelial 
cells protect the organs by covering and lining all body surfaces. Lining 
epithelial cells can be classified as simple and stratified epithelial cells. 
Simple epithelial cell has a single layer of cells, and the stratified one 
contains multiple cell layers.  
Due to the geometric shapes of the epithelial cells, they can be classified 
into three types: squamous, cuboidal and columnar. Thus, they are further 
divided as simple squamous, simple cuboidal and simple columnar; also 




Figure 2.17: Classification of epithelial cell. 
  Simple squamous is a monolayer of thin, flattened and scale like cells. 
Squamous shape generates large surface area that touches with lumen and 
basement membrane. The nucleus of this cell is large and with elliptically 
shape. Due to one cell thickness layer, small molecules are easily 
penetrating the membrane and pass the cell. Simple cuboidal is a monolayer 
of cells has length similar as width. It has large and spherical nuclei that 
usually at the central of the cell. Simple columnar epithelial cells are a 
monolayer of cells that are taller than width. This cell with taller property gives 
a great protection with a single layer. Molecules cannot pass this thick layer 
by diffusion, and can be absorbed by active transport to pass the layer. 
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Pseudo-stratified columnar epithelium in left corner of Figure 2.17 is the 
fourth type of simple epithelial cells. It is formed by more than one type of 
simple epithelial cell with nuclei at different levels. All the cells in 
pseudo-stratified columnar type are directly touching with the base 
membrane, but not all cells reach the free surface. Stratified Epithelium in 
right corner of Figure 2.17 is constructed by minimum two layers of cells, but 
only the bottom layer is attached to the base membrane. Thus, stratified 






2.6 Vascular endothelial cells 
Luminal surface of blood and lymphatic vessels are fully covered by 
vascular endothelial cells. It has various functions in vascular biology, such 
as tissue homeostasis, fibrinolysis and coagulation, blood-tissue exchange, 
vascular regulation, the vascularization of various tissues, and blood cell 
activation and migration during physiological and pathological processes 
(Risau 1995).  
2.6.1 Glycocalyx layer 
 
Figure 2.18: Electron microscopy image of coronary endothelial glycocalyx. 
(van den Berg, Vink et al. 2003) 
 An endo-capillary layer has been found on endothelial cells by Luft (Luft 
1966). This layer is un-informing with a fluffy structure is shown in Figure 2.18. 
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Figure 2.18 shows the shape of glycocalyx has a brush like conformation, 
and locates on the luminal surface of the endothelial cells. It has a negative 
charge and formed by a matrix of proteoglycans, glycolsaminoglycans, and 
glycoproteins. The shape and size of endothelial glycocalyx layer are affected 
by blood plasma proteins and molecules (Pries, Secomb et al. 2000).  
Furthermore, ionic strength, pH value of plasma and other factors in the 
micro environment have significantly influence the glycocalyx layer shape 
(Seog, Dean et al. 2005; van Haaren, VanBavel et al. 2005). Squire et al 
propose glycocalyx on cell membrane layer with is linked to actin 
cytoskeleton (Squire, Chew et al. 2001).  
Image (A) of Figure 2.19 shows complex distributed cytoplasmic structural 
actin (DCSA) network connect with apical and basal cell membranes 
physically. DCSA network is a signaling pathway from membrane to nucleus 
and able to transfer mechanical forces through the cells (Satcher, Dewey Jr 
et al. 1997). The glycocalyx is located on the luminal surface of the cell which 
connects the underlying endothelial cell cortical cytoskeleton.  
In Figure 2.19 (B), this model gives a definition of the endothelial 
glycocalyx which are formed by the matrix of macromolecules. Squire et al 
suggest the thickness of endothelial glycocalyx layer to be around 200 nm. 
The gap between paralleled fibrous of the glycocalyx layer is approximate 20 





Figure 2.19: Endothelial glycocalyx layer model 
A) Schematic illustration of Endothelial glycocalyx layer model presenting core protein 
arrangement and spacing of scattering centers along core proteins and their relationship to 
actin cytoskeleton as proposed by Squire. B) Idealized model for core protein clusters and 
cluster foci and their relationship to hexagonal actin lattice in cortical cytoskeleton 
(Weinbaum, Zhang et al. 2003).  
2.6.2 Composition of glycocalyx  
The endothelial glycocalyx with layer structure contains large amount of 
carbohydrate, form a line on the vascular endothelium which are connected 
with backbone molecules. Most of the molecules are proteoglycans and 
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glycoproteins, as well as some soluble molecules. A dynamic equilibrium 
exists between this layer of complex and the flowing blood, and continuously 
influences the glycocalyx thickness and components. Therefore, the 
glycocalyx is in a static condition, thus its components cannot be viewed and 
geometry is difficult to present (Lipowsky 2005).  
2.6.2.1 Proteoglycans 
The major functional backbone molecules of glycocalyx are formed by one 
of the most important component named proteoglycans which is O-glycosyl 
linkage c glycoproteins. Proteoglycans are found on the surface of 
endothelial cells and in the extra cellular matrix. It is affected by several 
growth factors such as fibroblast growth factor (Presta, Statuto et al. 1992), 
platelet-derived growth factor (Raines and Ross 1992) and transforming 
growth factor (Segarini PR 1989). 
Proteoglycans are formed by covalently banded core protein of 
carbohydrate polymers with long and un-branched structure which are known 
as glycosaminoglycans (Pries, Secomb et al. 2000). Different core proteins 
attached by different glycosaminoglycan chains which contain different size, 
number and properties. Some of the core proteins are bounded to the cell 
membrane while others are not, and these core proteins form different 
proteoglycan. There are six groups of core protein which are classified as: 
syndecan, glypican, perlecan, versican, mimecan and biglycan. The first 
three types of core protein are main proteins of endothelial cells. Moreover, 
syndecan and glypican proteins are connected with the cell membrane; 
perlecan is not directly incorporated to the cell membrane.   
2.6.2.2 Classification of Proteoglycans 
Syndecans have a firm connection to the cell membrane via a membrane 
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spanning domain (syndecans) (Carey 1997). Its tail penetrate inside the cell 
cytoplasm and connect with the endothelial cytoskeleton, leads to assisting in 
reorganization of the cytoskeleton (Yoneda and Couchman 2003). 
Endothelial cells contain three types of syndecan, each of them with three 
glycosaminoglycan attachment sites which are usually occupied by heparan 
sulphate (Rosenberg, Shworak et al. 1997). 
Glypican incorporate with the cell membrane via a 
glycosylphosphatidylinositol anchor (glypicans), and contains three or four 
glycosaminoglycans attachment sites which are only can be occupied by 
heparan sulphate (Fransson, Belting et al. 2004). The heparan sulphate 
chains attached on glypicans are typically combined with plasma membrane 
regions where contain caveolin-1 (Deurs, Roepstorff et al. 2003).   
Perlecan is secreted by endothelial cells and interacts with collagens, 
laminin, and other components within the membrane of the basement 
(Murdoch, Dodge et al. 1992). Except these main core proteins, other 
proteoglycans exist as the soluble element of the glycocalyx, such as 
mimecan and biglycan. These soluble proteoglycans stay in the glycocalyx or 
spread into the blood flow (Reitsma, Slaaf et al. 2007).  
2.6.2.3 Glycosaminoglycan chains 
Glycosaminoglycan chains are linear polysaccharides in the extracellular 
matrix that contain characteristic disaccharide unit (Jackson, Busch et al. 
1991). For endothelium glycocalyx, heparan sulphate, chondroitin sulphate, 
dermatan sulphate, keratan sulphate, and hyaluronan are five types of 
glycosaminoglycan chains that have been discovered yet (Reitsma, Slaaf et 
al. 2007).  
Among these glycosaminoglycan chains, heparan sulfate proteoglycans 
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are estimated 50 - 90 % of the total proteoglycans within the glycocalyx 
(Ihrcke, Wrenshall et al. 1993). 15 - 24 % of the proteoglycans are formed by 
chondroitin sulphate proteoglycans which locate on the cell surface 
(Rapraeger, Jalkanen et al. 1985). Most of both largest glycosaminoglycan 
chains are attached on core proteins of trans-membrane syndecans and 
membrane bound glypicans (Pries, Secomb et al. 2000). The number of 
glycosaminoglycan chains attached to the core proteins are influenced by 
many factors, such as physiological state and the location of the tissue 
(Geary, Koyama et al. 1995; Li, Brown et al. 1997). 
2.6.2.4 Glycoproteins 
Compare with proteoglycans, glycoproteins are also known as primary 
backbone molecules and contain long linear side chains which connect with 
the glycocalyx to the endothelial cell membrane. These endothelial 
glycoproteins typically contain adhesion molecules and components of the 
coagulation and fibrinolysis system. (Reitsma, Slaaf et al. 2007). Changing of 
glycoproteins present on the endothelial cell membrane depend on cell 
activation or stimulation.  
Sialic acid distributes widely in glycoproteins. It is a monosaccharide with a 
nine-carbon backbone and derivative of neuraminic acid (Varki, Cummings et 
al. 2009). High density of glycoproteins contain large amount of sialic acid 
form a negative charge on cell membranes and generate repulsion between 
cells (Fuster and Esko 2005). Most of the endothelial glycocalyx layers 




Figure 2.20: Schematic illustration of endothelial glycocalyx  
It contains proteoglycans and glycoproteins on the luminal surface of endothelial cells.  
Caveolin-1 forms as a tilted α shape connects with regions in the membrane where are 
located of glypicans with heparin sulphate chains. Trans-membrane syndecans contain both 
heparin sulphate and chondroitin sulphate chains are present as clusters. A glycoprotein 
contains short oligosaccharide branched chains and attached sialic acids are marked in the 
Figure. Hyaluronic acid is a long glycosaminoglycan chains weaves into the glycocalyx and 
binds with the cell membrane receptor CD44 which stay with caveolin. The cytoplasmic 
domains of syndecans could combine with molecules which connect to cytoskeletal elements 





2.7 Interactions between microcapsules and cells 
In recent years, progress have been developed in understanding the 
delivery mechanism of microcapsules into cells in vitro and in vivo 
(Sukhorukov, Rogach et al. 2007; Muñoz Javier, Kreft et al. 2008; An, 
Kavanoor et al. 2009; De Koker, De Geest et al. 2009; Rivera-Gil, De Koker 
et al. 2009; Vergaro, Scarlino et al. 2011). Internalization of microcapsules by 
cells was first reported by Gleb et al in 2005 (Sukhorukov, Rogach et al. 
2005). Diameter of 5 μm polyelectrolyte capsules and breast cancer cells of 
the cell line MDA-MB-435s used in the report. Figure 2.21 shows a 
successful internalization of capsules by breast cancer cells. 
 
Figure 2.21: Images of human breast cancer cell with internalized capsules. 
Left image is overlay of phase contrast and fluorescence image, and right image is 
fluorescence image. Capsules are coated with negatively charged fluorescent CdTe QDs 
(Sukhorukov, Rogach et al. 2005).   
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Internalized capsules with a non-spherical shape locate around the nuclei 
of cell. Non-internalized capsules are however still remaining in their original 
shape. After 48 hours capsules / cells co-incubation time, more than 95 % of 
cells contain capsules observed by CLSM. They also demonstrated a single 
cell is able to internalize up to 40 capsules. To further determine whether 
capsules are internalized by cells or not, pH-sensitive fluorescent 
seminaphtho rhodafluor 1 dye (SNARF1-1) is introduced.   
 
Figure 2.22: SNARF loaded capsules internalized by breast cancer cells.  
Image (A) and (B) are CLSM images; (C) is general process of the test. (Kreft, Javier et al. 
2007) 
  Kreft et al presented interactions between SNARF loaded capsules and 
breast cancer cells. After 5 hours of capsules / cells co-incubation time, 
culture medium is changed to an alkaline condition of pH 9.5. SNARF dye 
presents red colour in alkaline condition, and green colour in acidic 
environment of endosome. Image (B) of Figure 2.22 is the same cells in 
image (A) after another 30 min of co-incubation. The colour of capsules 
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changed from red to green proves they are internalized by the cell within 30 
min.  
  Koker et al published intracellular delivery of biodegradable microcapsules 
formed by Dextran Dulphate (DS) and Poly-L-arginine (PArg) to dendritic 
cells in 2007 (De Koker, De Geest et al. 2007). MTT assay is used to test 
cytotoxicity of DS/PArg capsules. They demonstrate moderate number of 
capsules is not significantly affect cells viability. Biocompatibility of these 
capsules is tested in vivo. 4 layers capsules are subcutaneous injected into 
mice, after 30 days, inflammation remains local and no necrosis is observed. 
 
Figure 2.23: CLSM images of tissue sections after injection of microcapsules. 
(De Koker, De Geest et al. 2007). 
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Figure 2.23 shows a large area of the injection site as an overlay of 
DS/PArg capsules (red) and nuclei (blue). Capsules with deformed and 
shrunk shape are internalized by cells; while non-internalized capsules 
remaining the same shape as injection. Moreover, internalization of capsules 
by cells always last for long time.  
  SEM images of capsules internalization by B50 rat neuronal cells has been 
reported by Pavlov et al in 2011 (Pavlov, Saez et al. 2011). In Figure 2.24, a 
capsule with intact CaCO3 particle is internalized by the cell is shown. 
Focused ion beam milling is used in Figure 2.24 (b), in upper corner, rigid 
particle of CaCO3 to provide a strong contrast.  
 
Figure 2.24: SEM images of a micro particle inside a neural cell. 
(a) a cell contains a capsule, (b) focused ion beam milling at the bulge area, magnified region 
of (b) in upper corner showing porous CaCO3 core (Pavlov, Sapelkin et al. 2011). 
  The above cells are all phagocytic cells, such as cancer cell. Internalization 
of capsules by non-phagocytic cells has not been published yet. Therefore, 
investigation of interactions between capsules and non-phagocytic cells 
becomes a great challenge.  
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3 Objectives and Approach 
  Microcapsules are suitable vehicle for various applications, most 
importantly as drug delivery. Thus, the aim of this project is to investigate the 
interactions between microcapsules and two types of cells namely epithelial 
and endothelial cells. The interactions of microcapsules and the cells are 
investigated by physical and biochemical stimuli.   
  First, the fabrication and characterization of microcapsules are carried out. 
Two typical types of microcapsules are fabricated through Layer-by-Layer 
(LbL) assembly technique. One is constructed by synthesis polyelectrolytes 
of PSS/PAH, and another is formed by biodegradable polyelectrolytes of 
DS/PArg or DS/PLL. Capsules are functionalized with super paramagnetic 
nanoparticles or gold nanoparticles. Fluorescent dyes and/ or enzyme are 
encapsulated for designed experiments.    
The interactions between capsules with magnetite nanoparticles and 
epithelial cells are performed by physical means. Magnetite nanoparticles 
modified DS/PLL-FITC capsules are prepared and co-incubated with 
epithelial cells. A magnet is placed under the cell container to provide 
magnetic field. Capsules with magnetite nanoparticles are attracted to the 
well bottom by the magnet. DS/PLL-FITC microcapsules are prepared as 
control sample. Due to cancer cells are able to internalize microcapsules in 
hours spontaneously (Sukhorukov, Rogach et al. 2005; De Koker, De Geest 
et al. 2007; De Cock, De Koker et al. 2010), 5 and 10 minutes are chosen as 
co-incubation time of both capsules with magnetite nanoparticles and control 
capsules. The comparison of capsules number and location in both samples 
is observed using CLSM. 
  The main part of this thesis focuses on investigation of interactions 
between capsules and non-phagocytic cell of Human Umbilical Vein 
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Endothelial cells (HUVECs). Discover the role of the glycocalyx of HUVECs 
on trans-membrane movement of microcapsules in vitro. Toxicity analysis of 
the polyelectrolytes is checked by co-incubation of sterilized PSS/PAH 
capsules and HUVECs. These capsules are treated by autoclaving 
procedure at 126 oC for 40 minutes, and then incubated with HUVECs for up 
to 14 days. Then, characterization of capsules affected by the culture 
medium is studied.  
The biochemical method of investigating interactions between HUVECs 
and capsules is performed by encapsulation of an enzyme named 
neuraminidase. Neuraminidase enzyme is able to cleave the neuraminic acid 
component of the glycocalyx on endothelial cells, such as sialic acid residues 
and N-acetyl-D-glucosaminyl residues of glycoproteins. Encapsulation 
efficiency and the release rate of neuraminidase in 4 layers capsules are 
analyzed. Samples of neuraminidase loaded capsules and HUVECs 
co-incubation and control samples are prepared for CLSM observation. 
Research of biological degradation of DS/PArg capsules in HUVECs is 
performed by distribution analysis of encapsulated TRITC-dextran in 
cytoplasm. Investigation of HUVECs transfection using co-incubation of cells 
with neuraminidase and DNA plasmid loaded capsules are also carried out. 
Green fluorescence protein expression of transfected HUVECs are checked 
by CLSM. Commercial transfection reagent Fugene 6 is tested as control.  
  The mechanisms of uptake of microcapsules by living cells are not fully 
understood and are still under investigation. The internalization and 
degradation of microcapsules by non-phagocytic cells had been not yet 
published. Therefore, the main experiment is aiming better performance of 
microcapsules with normal healthy cells in drug delivery system.     
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4 Materials  
4.1 Materials  
4.1.1 Polyelectrolytes for Capsule Preparation 
All polyelectrolytes used for microcapsules fabrication are shown in Table 
4.1. Two typical microcapsules were prepared from PSS/ PAH and 
degradable DS/ PArg (PLL) respectively. Figure 4.1 shows the chemical 
structural of the polyions. All the polyelectrolytes were purchased from Sigma 
Aldrich and used without further purification. 
Polyelectrolyte MW(kDa) Abbreviation 
Poly (styrenesulfonate sodium salt) 70 PSS 
Poly (Allylamine hydrochloride) 56 PAH 
Dextan sulfate sodium salt  100 DS 
Poly (l-arginine) hydrochloride 15 - 70 PArg 
FITC-labelled poly-L-Lysine 15 - 30  FITC - PLL 










4.1.2 Fluorescent dyes and labeling  
  Fluorescent dyes of TRITC and FITC w used for encapsulation or labeling. 
Molecular weights of both dyes are given in Table 4.2 as well as TRITC 
labeled dextran sulfate and BSA. The chemical structure of FITC and TRITC 
are shown in Figure 4.2. 
Reagent Mw(Da) Abbreviation 
Fluorescein isothiocyanate isomer I 389.38 FITC 





65 – 85 k TRITC-dextran 
Tetramethylrhodamine isothiocyanate–BSA 66 k TRITC-BSA 
Table 4.2: Overview of fluorescent dyes used for encapsulation or labeling. 
  
Figure 4.2: Structural formulas of fluorescent dyes. 
Structure of FITC (left) and TRITC (right). 
A general protocol for the modification of proteins, particularly 
immunoglobulin with TRITC (Hermanson 1996) is given below: 
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1: Protein solution of DS or BSA was prepared at concentration of 2 mg/ml in 
0.1M sodium carbonate with pH 9.0. 
2: In a dark environment, TRITC was dissolved in dry dimethyl sulfoxide 
(DMSO) at concentration of 1mg/ml. The solution was protected from light. 
3: TRITC solution (step 2) was added into the protein solution (step 1) with 
the ratio of 0.05:1. The number of fluorochrome molecules per protein 
molecule is defined as the F/P ratio. For TRITC labeled protein, the ratio is 
controlled in the range from 0.3 to 0.7.  
4: The solution was continuously stirred for 8 hours at 4 °C in the dark 
environment. 
5: Dialysis process was applied to remove the unlabeled TRITC. The solution 
was moved into the dialysis bags (MW cut-off 14 kDa) and immersed in 
Milli-Q water for one week. The water was changed twice every day, until no 
fluorescence was detectable in the external solution.  
The general reaction mechanism of TRITC and amine-containing molecules 
shows in Figure 4.3 
 
Figure 4.3: TRIT reacts with amine-containing molecules to create an isothiourea linkage. 
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The materials used for preparation of fluorescent dyes were purchased from 
Sigma Aldrich 
4.1.3 Super paramagnetic (Fe3O4) nanoparticles 
 These super paramagnetic nanoparticles are used for capsules 
functionalization. A magnetic field can be used to manipulate the motions of 
these magnetite nanoparticles. A stable aqueous solution of super 
paramagnetic (Fe3O4) nanoparticles were prepared by functionalizing the 
surface with tri-carboxylic citric acid using a well-established Massart’s 
co-precipitation method (Massart 1981), the general procedure are listed 
below:  
1: In a typical reaction, 0.86 g FeCl2 and 2.35 g FeCl3 were placed into a flask 
with three necks, and then 40 ml MillI-Q water was added. The reaction was 
carried out under argon protection. The three necks of the flask were sealed 
with temperature senor probe, incoming argon gas and water cooling system 
respectively.  
2: The solution was then heated to 80 oC, and then 5 ml of ammonium 
hydroxide (NH4OH) was injected using a syringe. The solution was 
continuously stirred and maintained at a constant temperature. The reaction 
mechanism is shown below:  
FeCl2 + FeCl3 + NH3 → Fe3O4 ↓ + NH4Cl 
3: After 30 minutes heating, 1 g of Citric Acid (CA) in 2 ml of water was added 
to the mixture. The temperature was then increased to 95 oC for another 90 
minutes.  
4: The solution and resultant products were moved into dialysis bag (Mw 
cut-off 14 kDa) after cool down to room temperature. The bag was immersed 
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in Milli-Q water to remove the excess unbound CA for 3 days. The water was 
changed twice every day. The magnetite nanoparticles surface consisted of 
adsorbed citric acid layer present electrically charged with size range from 10 
to 20 nanometers were obtained.  
The materials used for synthesis of Fe3O4 nanoparticles were purchased 
from Sigma Aldrich.  
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4.2 Human umbilical vein endothelial cells culture 
4.2.1 Culture medium preparation 
The human umbilical vein endothelial cells (HUVECs) purchased from 
Lonza, was cultured at 37 °C in 5 % CO2 incubator. Culture medium was 
changed every 2 or 3 days. The culture medium was prepared with several 
reagents and M199 medium. Typically 500 ml culture medium made from 500 
ml M199 medium and several reagents are given in Table 4.3. 
Reagent Concentration 
Foetal bovine serum 10 % 
β-endothelial cell growth factor 1 ng/ml 
Endothelial cell growth supplement from bovine 
neural extract 
3 µg/ml 
Thymidine 1.25 µg/ml 
Heparin 10 U/ml 
penicillin 100 U/ml 
streptomycin 100 µg/ml 
Table 4.3: Components of culture medium. 
Chemicals for the M199 medium and the foetal bovine serum were 
purchased from Invitrogen, and the remaining chemicals were purchased 
from Sigma Aldrich. 
Mixed solution was further sterilized by filtering through a 0.22 µm pore sterile 
filter (from Millipore). The sterilized medium was stored in a fridge at 8 oC for 
future use.  
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4.2.2 Trypsinization, cryopreservation and reawakening of 
HUVECs 
After HUVECs reached 80 % confluence, trypsin (0.25 % trypsin-EDTA) is 
used for cells subculture. Culture medium was washed using PBS buffer (3 - 
5 ml) for 10s. 2 ml of trypsin was added in the flask, and the flask was gently 
shaken. Cells morphology was checked using an optical microscopy. After 
the cells became rounded and detached from the flask, 5 ml culture medium 
was added to stop the trypsinization. The cells were centrifuged for 5 minutes 
at 1500 rpm. Then cells were washed with PBS buffer. Thus the cells were 
re-suspended in a pretreated flask at concentration of 5000 cells/ml. After 10 
passages, the cells were discarded. To prepare the cell flasks or cover slips, 
cell culture flasks were coated with collagen type I (5 - 10 µg/ml) at 37 oC for 
1 hour. Then flasks were gently washed using Phosphate Buffered Saline 
(PBS). 
For future use, HUVECs were preserved in liquid nitrogen. After 
trypsinization and centrifugation steps, the cells were re-suspended in a 
medium which contains 20 % FBS, 70 % HUVECs culture medium and 10 % 
Dimethyl sulphoxide (DMSO). Then cells were put into cryo-vials and placed 
into a cryo-box (Nalgene freezing container, Nalgene, Hereford UK) stored in 
a freezer at - 80 oC overnight. Then the vials were transfered into a liquid 
nitrogen cryo-bank for long term storage.  
To reawakening HUVECs, the vial was moved from liquid nitrogen and 
placed into 37 oC water bath. The medium was centrifuge for 5 minutes at 
1500 rpm. Cells were re-suspended in 5 ml of HUVECs culture medium. 
Then the cells were placed in a collagen pre-coated culture flask at 
concentration of 5000 cells/cm2, and transferred into an incubator with 37 oC 
and 5 % CO2.  
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All chemical were purchased from Sigma Aldrich.   
4.2.3 Immuno-fluorescent staining 
As the HUVECs is cultured on a collagen pre-coated glass slide, the 
staining process of the cells in vitro (Bai and Wang 2012) is performed as 
followed:   
1: All mediums and chemicals were pre-heated to 37 oC. The sample was 
washed with serum free M199 medium. 
2: Lectin Wheat Germ Agglutinin (WGA) (Sigma Aldrich) was used to stain 
β-(1-4)-N-acetly-D-glucosamine and N-acetylneuraminic of glycocalyx. Cells 
were incubated with WGA at the concentration of 10 μg/ml for 15 minutes. 
3: Sample was washed 3 times with serum free M199 medium to remove 
WGA solution. Then cell tracker red CMTPX (Invitrogen) at 0.5 μM was 
added for cytoplasm staining for 15 minutes. 
4: Sample was washed 3 times with serum free M199 medium to remove cell 
tracker red CMTPX solution. 5 μg/ml of hochest 33342 (Invitrogen) was 
added to stain nucleus for 10 minutes.  
5: After all these staining steps, the sample was washed with serum free 
M199 medium, and cell culture medium was added.  
Then cells were ready for CLSM observation.  
4.2.4 Function of neuraminidase 
According to the product information from Sigma Aldrich, neuraminidase 
enzyme belongs to hydrolase enzymes. It plays an important role in influenza 
virus releasing and virus spreading. In this study, neuraminidase is used to 
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cleave the neuraminic acid component of the endothelial cells glycocalyx, 




Figure 4.4: Structure of neuraminidase. 
Neuraminidase of influenza virus (Colman 1994). 
The chemical structural of neuraminidase is shown in Figure 4.4. The 
neuraminidase contains single polypeptide chain with six conserved polar 
amino acids, followed by hydrophilic, variable amino acids and a hydrophobic 
trans-membrane region that provides the anchor for the stalk and the head 
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domains (Varghese, McKimm‐Breschkin et al. 1992; Gouda, Aly et al. 
2011). 
The neuraminidase monomer mass is ~ 50 - 60 kDa, most often as 64 -66 
kDa. It has highest activity in pH range from 5.0 to 5.5. While at pH 7.0 in 
phosphate buffer, its activity reduce to 30 - 50% (Cassidy, Jourdian et al. 
1965). Neuraminidase from Clostridium perfringens (C. welchii) Type V, 
lyophilized powder was purchased from Sigma Aldrich without any further 
purification. 
4.3 RCA cleaning 
Silicon wafers, glasses and beakers were cleaned by RCA-1 process to 
remove any potential organic contaminants. The general procedure (Kern 
1970) is followed. 
1: Isopropanol and water were mixed at ratio of 1:1. Substrates were placed 
into the solution and sonicated for 5 minutes.  
2: Water, ammonium hydroxide (NH4OH) and hydrogen peroxide (H2O2) were 
mixed at ratio of 5:1:1. Substrates were washed with Milli-Q water, and then 
immersed into the solution.  
3: The solution was heated to 75 oC for 15 minutes in water bath. Any organic 
materials were degraded in this step. 
4: The substrates were washed with plenty of Milli-Q water after cooled to 
room temperature.  
Now the substrates were ready to use for capsules preparation. Chemical 
used for RCA-1 process were purchased from Sigma Aldrich. 
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4.4 Pierce BCA protein assay 
In 1985, Smith et al (Smith, Krohn et al. 1985) discovered a biochemical 
assay named Bicinchoninic Acid (BCA) assay. It is able to measure the 
protein’s total concentration within the range from 0.5 μg/ml to 1.5 mg/ml. The 
colour of protein changes from green to dark purple as the concentration 
increasing. There are two primary reactions in the BCA assay. One is Cu2+ 
ions in cupric sulfate are reduced by protein’s peptide bonds to Cu+. Thus the 
amount of reduced Cu2+ is affected by the amount of protein exist in the 
solution. Another one is two molecules of BCA chelate with one cupric ion. A 
purple coloured component is created by the second reaction, and has a 
strong light absorption at wavelength of 562 nm. At this wavelength, a series 
concentration of proteins are nearly linear over a broad working range (Olson 
BJ 2007).  
Peptide bonds of protein prefer high temperatures from 37 to 60 oC to form 
the reaction complex. Therefore, BCA assay is incubated in this temperature 
range to raise assay sensitivity. Protein concentrations are measured and 
recorded with reference to standards of Bovine Serum Albumin (BSA). A 
series of BSA dilutions of known concentration were prepared as calibration 
(Olson BJ 2007). 
1: BCA working reagent was prepared by mixing reagent A and reagent B of 
Pierce BCA protein assay kit at ratio of 50:1. 
2: 25 μL of series BSA dilutions were pipetted into 24 well micro plates in the 
working range between 20 – 2000 μg/ml. 
3: 200 μL of the BCA working reagent was added to each well. Then the 
micro plate was gently shaken for 30 seconds.  
4: The micro plate was incubated at 37 oC for 30 minutes.  
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5: The absorbance wavelengths of solutions were measure in each well at 
562 nm using spectrophotometer.  
The unknown concentrations of samples were measured with same 
method and calculated using the calibration curve of standard BSA. Pierce 
BCA protein assay kit was purchased from Thermo Scientific. 
4.5 Laboratory equipment 
Device Type 
Centrifuges Eppendorf, centrifuge 5417c and 5418. 
Shaker IKA Vortex genius 3.  
Ultrasonic bath Elma S 15 H, Elmasonic. 
Hot plate stirrer IKA-Werke RET basic C + ETS-D4 fuzzy. 
Autoclave Prestige Medical, classic. 
Electronic balance Ser.No; 2905662. A&D company. Limited 
Dialysis bag Carl Roth GmbH + Co. KG, Dialysis 
membranes Mw cut-off 14 kDa. 
pH paper Sigma Aldrich, pH 1 - 11 Triple colour 
chart. 
Tubes  Eppendorf, Standard micro test tube 
Disposable cuvettes Plastibrand, 
polymethylmethacrylat 
Carl Roth GmbH + Co. KG, PMMA: 300 - 
900 nm 






5.1 Zeta potential measurements 
The electro kinetic potential in colloidal systems is called zeta potential. 
Distribution of ion in the medium is affected by the presenting particle surface 
net charge. Concentration of counterions is higher in the region that closes to 
the particle. In this region, an electrical double layer of the particle liquid 
interface is formed. Stern layer is inner region and Gouy-Chapman layer is 
outer region. They are classified by the variation in electrical potential as a 
function of distance from a charged substrate. Figure 5.1 shows zeta 
potential and Zetasizer Nano cells.   
Ions in Stern layer are strongly bounded and not affected by thermal 
motion. The thickness of Stern layer is a single hydrated ionic layer. While 
ions in Gouy-Chapman layer also called diffuse layer are less bounded, and 
its distribution depends on electrostatic forces and thermal motion. When 
particle moves, ions inside the boundary of electrical double layer are moved 
with the particle. Outside the boundary, ions are not bounded and moved with 
the particle. This boundary is called slipping plane, and the electric potential 
at this plane between the double layer and the surrounding medium is called 
zeta potential. 
Zeta potential is determined by the effective charge on the particle and 
influences the electrostatic repulsion between the particles. Thus, zeta 
potential is directly affecting the stability of colloidal dispersion. Particles with 
high value of zeta potential remain non-aggregate dispersion and electrical 
stability. Otherwise, colloid particles with low zeta potential become 





Figure 5.1: Schematic representation of zeta potential and Zetasizer Nano cells. 
In colloid system, difference of ionic concentration and potential are used as a function of 
distance from the charged surface of a particle (Instruments 2004). 
 89 
 
The charged surface of colloidal particle is able to prevent particle 
precipitation in solution. The charge can be determined by measuring its 
electrophoretic mobility in an electrical field. Zeta potential represents ions 
mobility of particles surround with electric field at slipping plane. Therefore, 
the actually potential of particle surface cannot be measured, due to ions in 
Stern layer are not able to move. Smoluchowski equation shows the 
relationship between zeta potential ζ at the interface and the electrophoretic 
mobility υE (Hunter 1981). 
        𝟎  
 
   
  +       Eq. 5.1 
ε0: relative dielectric constant.      
εr: vacuum electrical permittivity.  
μ: solution viscosity.       
r: particle radius.      
k: Debye–Hückel parameter.  
Zeta Potential measurements of particles and capsules were using 
Zetasizer Nano (Malvern Instruments, Germany). The values of measured 
potential are averaged from 5 measurement cycles, each of the 
measurement have 10 single measurements. Disposable folded capillary 






5.2 Fluorescence spectroscopy 
Fluorescence spectroscopy also known as fluorometry or 
spectro-fluorometry is an electromagnetic spectroscopy which is able to 
measure and analysis fluorescence of substance. After photon adsorption, an 
electron or atom is in an excited state, emission of photons brings them back 
to the ground state. The process is called luminescence which is simply 
defined as emission of light from substance.   
Figure 5.2 shows a typical fluorescence spectroscopy. Xenon lamp has 
high intensity at wavelengths above 250 nm, and provides source of exciting 
light. The monochromators are performed to select the wavelengths of 
excitation and emission. Shutters are used to remove the exciting light or 
shut off the emission channel. The excitation light is reflected to a reference 
cell that contains a stable reference fluorophores by beam splitter. 
Photomultiplier tubes are working as a detector for fluorescence. The results 
are generally presented in graphical form stored digitally (Lakowicz 2006). 
Fluorescence measurement is used to determine encapsulation and 
releasing efficiency of encapsulated fluorescent substance. Intensities of 
fluorescence are mostly linear with increasing concentrations of dye. 
Therefore, series of known concentrations of dye are measured as calibration. 




Figure 5.2: Schematic illustration of a general fluorescence spectroscopy.  
(Lakowicz 2006). 
FluoroMax and Perkin-Elmer LS55 fluorescence spectrophotometers were 
using for fluorometry measurements. Disposable 4.5 ml and 1.5 ml cuvettes 






  Two solutions with same material but different colour, normally the 
deeper colour one is considered with higher concentration. Colorimeter is 
defined as intensity measurement of visible light in a wide wavelength range 
of the given sample. Principle theory of spectrophotometer is measuring the 
concentrations of substances with colours. The measurement is based on 
light radiation absorption of solution at certain wavelength. At the wavelength, 
sample has maximum light absorption and minimum light transmission.    
The term of transmittance is defined as the ratio of transmitted light of 
sample to incident light. The transmission is affected by the path length of the 
light passed. Light absorption is increased with the path length increasing 
and results light transmission decreasing. Therefore, the relationship among 
absorbance of light, concentration of substance and path length are 
summarized in Beer-Lambert Law: 
     
𝑰𝟎
𝑰
  𝑪 ,      
𝑰
𝑰𝟎
  𝟎  𝑪   Eq. 5.2 
I0 is the incident light and I is the transmitted light; C is concentration of the 
sample and L is the length of light path through the solution; K is 
proportionality constant named molar extinction coefficient or molar 
absorptivity with unit of liter / (mol×cm). 
The major function of spectrophotometer is selectively tests the intensity of 





Figure 5.3: The basic components of colorimeters and spectrophotometers.  
A: source of radiant energy; B: means of spectral isolation; C: adjustable diaphragm or 
amplification stage; D: cuvette as sample container; E: radiant energy detector; F: output 
system (Varcoe 2001). 
Light radiation as a stable and continues spectrum from 200 to 1000 nm is 
supplied by energy source. Spectral Isolation is used to filter out the 
unrequired wavelengths. Adjustable diaphragm modifies the light intensity to 
regulation. For sample container, glass cuvettes can be used in the range of 
wavelength between 320 and 1000 nm. However, only quartz cuvettes can 
be used for wavelength below 320 nm.  
In the experiment, samples were prepared with Pierce BCA protein assay 
kit from Thermo Scientific. The instrument used to measure the absorbance 
at the wavelength of 562 nm is Multiskan ascent with mode of 354 from 





5.4 Confocal laser scanning microscopy 
Confocal Laser Scanning Microscopy (CLSM) is a non-destructive imaging 
technique, used for visualization and three-dimensional reconstruction with 
high resolution of biological samples. CLSM has better performance than 
conventional optical microscopy in imaging technology. Such as controllable 
depth of field imaging, elimination of background information from the focal 
plane, and sequential scanning of the sample with thickness up to 100 μm (N. 
S. Claxton 2006). There are three modes of confocal microscope which are 
fluorescence, transmission and reflection.  
In 1957, the principle of confocal microscopy was first introduced by Marvin 
Minsky (Minsky 1961). However, the limitation of traditional microscopy 
techniques results low resolution images. In 1974, a laser scanning process 
was created by Thomas and Christoph Cremer (Cremer and Cremer 1974). 
With this technique, 3D structure of sample can be scanned point by point 
with the focus laser beam and reconstructed by electronic instrument.  
Figure 5.4 shows optical pathway and typical components in CLSM. 
Excitation source system provides coherent light such as laser. The emitted 
laser passes through a pinhole aperture, and then is reflected by a 
dichromatic mirror to the sample. The dichromatic mirror is able to reflect the 
trapping laser into the optical path of the microscope and transmit the 
illuminative light (Neuman and Block 2004). While laser hits and scans 
across the sample in a pre-set focal plane, the scanned points emit 
secondary fluorescence. The lights reflected or emitted by the sample pass 
back through the dichromatic mirror and are focused as a confocal point at 




Figure 5.4: Schematic illustration of components in confocal laser scanning microscopy.  
(N. S. Claxton 2006). 
Fluorescence emission occurs at points on the sample only in focus plane 
can pass through the detector pinhole aperture. In Figure 5.4, out of focus 
fluorescence emission light rays emitted above and below the focus plane 
are all eliminated. After passing detector pinhole aperture, the laser is 
collected by photomultiplier and transformed to data spot by computer.  
Sample is scanned at the focal plane by a process named fly-back. Two 
oscillating mirrors of CLSM are used to control the focused laser beam scan a 
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desired part of sample in a raster pattern. Laser beam is moved from left to 
right along x - axis by one mirror, and along y – axis by another mirror. After 
scanning the sample along x - axis, the laser beam return to the initial 
position of the single scan and shift along y - axis to start a new single scan 
along x - axis (Webb 1996). The image of sample is point by point 
reconstructed from emission photon signals. Photons at each scanned point 
are collected by photomultiplier detector and transferred from an electrical 
signal to pixels.  
A stepper motor controlled by computer is used to move microscope stage 
up and down and determines the focal plane. Image of the sample at z - axis 
can be recorded by continues moving the stage along z - axis after each x - y 
axis scanning. These data are converted into x - z and y - z plane, include x - 
y plane, the three dimensional reconstruction of the specimen are presented. 
This imaging process of CLSM is called sequential scanning and the 
minimum depth along z - axis is several nanometers.    
Generally, a modern confocal fluorescence microscope contains several 
laser source systems for fluorophores excitation. Therefore, samples with 
more than one staining fluorophores can be imaged and presented in multiple 
colours. This function of CLSM is very important for cells with capsules 
studies, due to labeled dyes of sample up to 3 colours. 
CLSM used to measure the aqueous samples is Leica TCS SP2 inverted 
confocal microscope system (Leica, Germany) equipped with a 63x oil 
immersion objective having a numerical aperture of 1.20. Laser of Ar - ion 
(488 nm) and a He - Ne (543 nm) as well as ultraviolet visible infrared (350 
nm) are used as excitation sources to the fluorophore stained in the sample. 
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5.5 Scanning electron microscopy (SEM) 
SEM is one of the electron microscopes with a focused beam of high 
energy electrons to scan the sample and generate images. Interactions 
between electrons and atoms of sample are transferred to signals, and then 
present information such as morphology, composition and electrical 
conductivity of the sample.  
5.5.1 Principles of SEM 
Figure 5.5 shows components of SEM. A typical SEM contains electron 
column, scanning system, detectors, display, vacuum system and electronics 
controls. Energy between 0.2 keV and 40 keV of thermionically electron 
beam is emitted by an electron gun. Then the beam is focused by condenser 
lens or electromagnetic lens to a spot with diameter in a range from 0.4 nm to 
5 nm. The electron beam follows a vertical path through scanning coils in the 
electron column, and is deflected by the final lens in x - axis and y - axis. 
Therefore images of a rectangular area on the surface of specimen can be 
scanned in a raster fashion.  
Because continue random scattering and absorption of the specimen, 
energy of electrons is lost while electron beam hits the specimen. The energy 
loss from electron beam and gain to the specimen causes reflection of high 
energy electrons, emission of secondary electrons and the emission of 
electromagnetic radiation. Signals are amplified by electronic amplifiers, and 
transferred to image with different brightness in output system. Thus the final 
image obtained by the computer is distribution map of the emitted signals 




Figure 5.5: Schematic illustration of typical scanning electron microscopy components  
There are several signal detectors of SEM, two typical signal detectors are 
Secondary Electron Detector (SED) and Back Scattered Electron Detector 
(BSED). SED is able to present the morphology and topography of the 
specimen. Low energy (less than 50 eV) secondary electrons are emitted 
from atoms on the surface of specimen by inelastic scattering interactions 
with beam electrons.  
The secondary electrons are detected by an Everhart-Thornley detector 
(Everhart and Thornley 1960). The number of secondary electrons collected 
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by the detector affects brightness of the signal. Generally, steep surfaces and 
edges are brighter than flat surfaces of the specimen. SEM has narrow 
electron beam which leads to a large depth of field. Thus, secondary 
electrons are able to generate high resolution images of specimen, and 
present details in 1 nm size.  
BSED collects electrons reflected by the specimen, and intensity of the 
signal generated from the scanned area is depended on the atomic number. 
Area with high average atomic number appears brighter than area with low 
atomic number. Therefore, BSED is well used to present contrasts of 
composition in multiphase samples. 
5.5.2 Focused ion beam 
The Focused Ion Beam also known as FIB technique was developed in 
1980s. A typical FIB contains ion column, work chamber, vacuum system and 
the gas system. Similar as SEM work with a focused electron beam, the FIB 
system work with a focused ions beam instead. Low beam currents of FIB 
systems are used for sample imaging, while high beam currents are used for 
sample sputtering or milling. 
Figure 5.6 shows the components of the FIB column. The chamber of FIB 
system is similar as SEM, requires a vacuum of 1 × 10−7 mbar. The ion beam 
is generated from a liquid metal ion source. Generally, the energy and 







Figure 5.6: Schematic diagram of components in an ion column. 
(Reyntjens and Puers 2001).  
After passing spray aperture, the ion beam is condensed in the first 
electrostatic lens and adjusted by upper octopole. Blanking deflector and 
blanking aperture are used for blanking the ion beam. Lower octopole is used 
for raster scanning of the desired area on specimen. The second electrostatic 
lens focuses the ion beam to a fine spot for high resolution imaging. 
Secondary particles such as neutral atoms, ions and electrons are collected 
by multichannel plate and converted to image (Reyntjens and Puers 2001). 
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Because ions are larger and heavier than electrons, it cannot easily 
penetrate atoms of the sample. Ion beam with high current can be used to 
removal of sample material. Figure 5.7 shows physical sputtering of sample 
material. A desired rectangle etching shape on the sample obtained by 
continues scanning with the high current ion beam in the pre-set area. The 
milling depth from surface of the specimen can be varied from few 
nanometers to micrometers with different beam energy. The milling depth 
also depends on the material of the specimen as well as the angle between 
the ion beam and sample surface.  
 
Figure 5.7: General milling process on a substrate with focused ion beam.  
(Reyntjens and Puers 2001) 
  In this report, biological samples of endothelial cells with microcapsules 
were investigated by the scanning electron microcopy with focused ion beam 
of FEI Quanta 3D FEG, Dual Beam FIB-SEM instrument system equipped 
with Oxford Instruments. 
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5.5.3 SEM samples preparation. 
Working chamber of SEM and FIB is high vacuumed, thus samples placed 
in the chamber must be completely dried. Otherwise, the chamber may loss 
the vacuum during observation of sample. Samples must be electrically 
conductive at the surface and electrically grounded to avoid the accumulation 
of electrostatic charge at the surface.  
No further preparation for electrically conductive samples. However, many 
biological and materials specimens are insulators. Therefore, ultrathin layer 
of electrically conducting material coating is performed for non-conductive 
samples. A standard method for preparing non-conducting or poorly 
conducting specimens for SEM is performed by sputter coater. It is working in 
vacuum chamber with an electric field and argon gas. A thin layer of 
conducting material cover the specimen surface is produced by sputter 
deposition process. Both capsules and cells samples were coated before 
SEM imaging.  
Biological samples are pre-treated by fixation and dehydration process to 
preserve their native structure before SEM observation. Fixation is a process 
of stop any ongoing biochemical reactions and avoids autolysis or 
putrefaction of the biological tissues. One of the most used chemical for 
fixation of biological samples is formalin. It is a crosslinking fixative and able 
to form covalent chemical bonds between proteins. Endothelial cells were 
fixed by fully immersed with 5 % formaldehyde for 10 minutes and then 
washed with PBS buffer. After fixation process, cell samples were stored in 
PBS medium in fridge at 4 oC.   
Dehydration is defined as a process of losing water from tissues or cells. It 
can be processed by heating or dehydrating agents. A typical dehydration 
process is followed by sequentially wash the biological samples in methanol 
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with increased concentrations. Biological sample is first washed with 
concentration of 20 %, 40 % and 60 % methanol for 5 minutes of each 
washing step. Then raise the concentration of methanol to 80 % wash the 
sample for 3 minutes. At last 100 % methanol is used to wash the sample for 
30 seconds. Remove the methanol and leave the sample in dry seal vacuum 
desiccator with calcium chloride anhydrous for drying.   
  In this report, samples of gold coating were using Agar auto sputter coater 
from Agar Scientific Elektron Technology UK Ltd, and carbon coating were 
using Balzers CED 030 carbon evaporator. Conductive carbon cement from 
Plano GmbH of Germany was used to fix the sample on a SEM metal holder. 
5.6 Transmission electron microscopy 
Transmission electron microscopy (TEM) is able to provide information 
about the inner structure of the sample. The electrons are transmitted 
through the sample, and an image is generated onto an imaging device or to 
be detected by a sensor.  
 
Figure 5.8: Photograph of transmission electron microscopy. 
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TEM was used to investigate the aggregation of gold nanoparticles in the 
shell of microcapsules. The contrast of the TEM image is affected by the 
different densities between metal nanoparticles and polyelectrolytes. One 
drop (about 5 μL) of capsules solution was pipetted onto a carbon coated 
copper grid and investigated using JEOL JEM 2010 transmission electron 





6 Microcapsules preparation and functionalization 
  This section provides details of capsules preparation and functionalization 
for the following experiments. All polyelectrolyte microcapsules are produced 
with CaCO3 template cores. Capsules modified with magnetite nanoparticles 
are used for physical treatment with epithelial cells. Capsules contain 
neuraminidase and labeled with gold nanoparticles (GNPs) are prepared for 
biochemical treatment with endothelial cells. The GNPs are specific need for 
investigation by Scanning electron microscopy with focused ion beam. 
6.1 Preparation of CaCO3 micro particles 
Calcium carbonate micro particles with porosity, uniform, almost spherical 
shape and narrow size distribution are fabricated from supersaturated 
solution by colloidal crystallization. There are two steps of CaCO3 formation, 
first step is simultaneous and rapid nucleation, and the second step is growth 
also called aging and agglomeration (Otakar Söhnel 1992). Metastable 
precursor of calcite is the reason to form amorphous calcium carbonate, and 
the number of the growing spherical particles as well as the mass density 
remains constant after a short nucleation period. Figure 6.1 shows overview 
image, spherical and cubic shape of CaCO3 cores. Due to calcite is the only 
thermodynamically stable modification of all CaCO3 formations, amorphous 
CaCO3 becomes crystal cubic structure after a certain time (Bolze, Peng et al. 
2002).  
The process is started by mixing calcium chloride and sodium carbonate 
with equal concentration and volume. The mixed solution is placed on the 
magnetic stirrer with continues stirring. While mix the two solutions, the 
amorphous precipitate appeared instantly, but the micro particles with 4μm 
diameter are formed more slowly. The size of the micro particles increase 
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with time, and the diameter could form up to 10 μm with the same particle 
morphology (Sukhorukov, Volodkin et al. 2004). 
  
  
Figure 6.1: SEM images of CaCO3. 
Overview of uniform CaCO3 cores (top image), spherical shape (bottom left) and cubic shape 
(bottom right) of CaCO3 cores.  
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In a typical experiment, the template core of CaCO3 was fabricated by 
mixing 0.33 M CaCl2 and equal volume of 0.33 M Na2CO3 solution into a 
beaker with stirring for 30 seconds at room temperature (Sukhorukov, 
Volodkin et al. 2004). Subsequently, the solution was collected into tubes and 
applied three centrifugation and washing steps with MillI-Q water to remove 
residual salts and unreacted pieces. Spherical shaped CaCO3 microparticles 
with a rather uniform average ~4 μm diameter were obtained. The porosity of 
CaCO3 particles provides a large surface area and has the ability to capture 
macromolecules effectively. For long term dry storage, the micro particles 
were rinsed with ethanol and dried. For short term storage, the suspension 
was kept at 4 oC in fridge.  
  
Figure 6.2: Preloading TRITC-dextran/ neuraminidase into CaCO3 core. 
Synthesis of neuraminidase (and, or TRICT-dextran) loaded CaCO3 microparticles by 
co-precipitating CaCl2 and Na2CO3 in the presence of neuraminidase. 
Calcium carbonate microparticles are more biocompatible than other 
templates for LbL encapsulation of proteins and enzymes (Petrov, Volodkin et 
al. 2005). Figure 6.2 shows a method of pre-loading (see (Petrov, Volodkin et 
al. 2005) for details) was performed for TRICT-dextran encapsulation. 0.5 
mg/mL of TRICT-dextran (red stain for visualization purpose) was premixed 
with CaCl2 or Na2CO3 aqueous solutions; protein was captured by growing 
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CaCO3 microspheres in the process of their formation named co-precipitation 
process. For neuraminidase-loaded microcapsules, 2 mg/ml neuraminidase 
was also encapsulated by the pre-loading method. Pre-loaded 
TRITC-dextran is for observing capsules with CLSM, and neuraminidase is 
for cleaving glycocalyx of endothelial cells. 
6.2 Capsule preparation 
Preparation of microcapsules with different shell materials requires 
different strategies such as core pretreatment, polyelectrolyte coating, and 
core dissolution. The alternating adsorption of polyelectrolytes onto the 
surface of CaCO3 particles was produced by immerse the particles into 2 
mg/ml oppositely charged polymer solutions with 0.5 M sodium chloride at a 
pH between 5 and 7. The polyelectrolyte absorption time required at least 15 
minutes with continues shaking to fully cover the core particles surface. After 
each layer had been absorbed, core particles were centrifuged and washed 
with Milli-Q water for three times to remove the uncoated polymer. Figure 6.3 
shows the capsules preparation and functionalization with nanoparticles. 
Core particles aggregation may appear after several layers of 
polyelectrolyte was coated, depending on the size of the particles. 10 
seconds ultrasonic bath was introduced to reduce the aggregation of the 
particles. After the desired number of capsule layers had been coated, 
CaCO3 template core particles were dissolved by adding 0.2 M EDTA at pH 7 
for three times. The capsules were then centrifuged and washed 3 times with 
Milli-Q water. They were seen to have rather uniform size and shape, with the 





Figure 6.3: Capsules preparation and functionalize with nanoparticles.  
(A) At least 2 layers of polyelectrolytes cover CaCO3 particle which contains pre-loaded 
substance; (B) Modify capsule with nanoparticles; (C) Desired number of layers coated; (D) 
Hollow capsule obtained after CaCO3 dissolution. 
Find out the zeta potential at interface between solid and liquid are very 
important for polymer applications (Werner, König et al. 1999). As a solid 
presents in aqueous medium, at the interface, free ions are rearranged to 
form a region with certain charge density. Charges of the capsules each layer 
as well as the CaCO3 core were measured using Zetasizer Nano and shown 
in Figure 6.4. Zeta potential measurement is carried out by adding 40 μL of 
capsules solution into the Zetasizer cuvette and filled with Milli-Q water with 
pH at 7. From Figure 6.4, zeta potential value changes from positive to 
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negative and repeat the changing during polyanionic and polycationic layers 
deposition. The potential values for each even or odd layer are similar. The 
reversed zeta potentials also prove charge overcompensation after every 
successful polymer layer deposition. 
 
Figure 6.4: Schematic illustration of Zeta potential of capsules during LbL process. 
Zeta potentials of samples are measured in Milli-Q water with pH at 7. 
Capsules work with biological cells is better to be biocompatible and bio 
friendly. Negatively charged Dextran sulfate sodium salt (DS) and positively 
charged poly-L-lysine (PLL) as well as poly-L-arginine (PArg) are 
biodegradable polyelectrolytes used for capsules preparation. Poly (styrene 
sulfonate sodium salt) (PSS) with negative charge and Poly (allylamine 
hydrochloride) (PAH) with positive charge are used for synthetic capsules 




Figure 6.5: SEM image of dried hollow microcapsules with diameter around 4 μm. 
  Microcapsules morphology and size were checked using SEM after 
fabrication. SEM sample were prepared by pipet one drop (about 5 to 10μL) 
of hollow capsules solution on a SEM metal holder with a standard carbon 
conductive adhesive tab on the surface. Then, the sample was leaved in dry 
seal vacuum desiccator with calcium chloride anhydrous overnight. The 
sample was completely dried in the next day. In Figure 6.5, SEM image 
shows the capsule with a diameter around 4 μm obtained after core 
dissolution. Without the spherical template, capsules are collapsed. Gold 
nanoparticles and iron nanoparticles incorporated as layer constituents do 
not affect capsules morphology in dried status.   
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6.3 Capsules functionalized by gold nanoparticles 
Gold nanoparticles (GNPs) have several advantage properties such as 
high charge density, small size, and light absorption. These characteristics of 
GNP make it well to functionalize polyelectrolyte microcapsules. GNPs can 
be coated by simply immerse the capsules into a mixed solution with water 
and nanoparticles with continues stirring. Because charge of gold 
nanoparticles is negative, it can be coated as a layer after positively charged 
layer. With a certain concentration of GNPs, it cannot fully cover the surface 
of previous layer. Thus, to achieve charge overcompensation, coating 
additional layer of previous polymer is needed. Therefore, the nanoparticles 
are coated in microcapsules shell. 
There are two types of GNPs which are aggregated and non-aggregated 
GNPs. Aggregates of GNPs are premixed gold colloid solution with certain 
amount of NaCl for few seconds. GNPs can incorporate with positively 
charged polyelectrolytes solution, then deposit as a positively charged layer. 
In this case, no additional positively charged layer is required, and the 
following negatively charged polymer can be directly coated. Because 
polyelectrolyte solution contains ~0.5 M NaCl, after incorporate with 
polyelectrolyte, GNPs change to aggregated GNPs. 
     
Figure 6.6: images of non- aggregated (left) and aggregated (right) 20 nm GNPs. 
Non-aggregated colloid gold nanoparticles present red colour in solution 
show in left image of Figure 6.6. In the right image of Figure 6.6, because 
additional ions present in the solution, colour of aggregated gold 
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nanoparticles is changed from red to blue or purple. The phenomenon of 
aggregation or flocculation of gold colloid particles in solution is formed by 
“cross-linking” agent. Ligands with single charge affect GNPs assemble 
slowly to string structures. While ligands with multiple charges can force the 
GNPs form cluster structures (Olivier and Sorensen 1990). There is no 
obvious difference between aggregated and non-aggregated GNPs modified 
capsules with cells samples under SEM investigation. Figure 6.7 shows the 
TEM image of capsules contain non-aggregated GNPs. The black dots in the 
gray colour capsule are GNPs. 
 
Figure 6.7: TEM image of capsules contain gold nanoparticles.  
These gold nanoparticles are used for capsules observation with SEM With 
focused ion beam. The inside area of the cells and capsules are able to be 
observed. After ion beam milling on desired area of sample, the cross section 
shows the z – axis of the area. With the cross section, location of capsules is 
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below or above the cell membrane can be directly seen. GNP provides good 
contrast in images taken by back scattered detector. They are very bright 
dots, help to distinguish capsules and other intercellular or extracellular 
matrix.  
6.4 Magnetite nanoparticles functionalized microcapsules 
Magnetite (Fe3O4) nanoparticles with an average size around 10 to 20 nm, 
stabilized with tetramethyl ammonium hydroxide, were synthesized in water 
according to the method presents in 4.1.3 (Massart 1981). 
Fe3O4 nanoparticles were coated by re-suspended CaCO3 particles with 
PLL as outmost layer into iron nanoparticles solution. Then the capsule walls 
were deposited with magnetite nanoparticles. Same as gold nanoparticles, 
the magnetite nanoparticles cannot fully cover the previous layer. Thus 
additional layer of PLL is formed as positively charged layer to cover the iron 
nanoparticles. Size of Magnetite nanoparticles were measured using 
Zetasizer Nano. The result shows ~80% nanoparticles with diameter around 
30 nm. Zeta potential is also measured using Zetasizer Nano as -22.3 mV.  
Figure 6.8 shows the TEM image of capsules with magnetite nanoparticles. 
Iron nanoparticles are incorporated in shell of capsule. Bottom left image of 
Figure 6.8 is capsules with magnetite nanoparticles suspended in deionized 
water, and right image is capsules with magnetite nanoparticles treated by a 
magnet after 3 minutes. Figure 6.8 shows capsules with magnetite 
nanoparticles are attracted by a magnet on the wall of the tube, not 
precipitate at the bottom. Magnetite nanoparticles incorporated capsules are 
prepared for physical treatment with epithelial cells. 
Polyelectrolyte microcapsules are prepared by LbL technique. All capsules 
are fresh produced the same day or one day before investigation. As the 
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amount of substance released is increasing with time, encapsulated 
substances release test is performed just after capsules fabrication. 
 
   
Figure 6.8: Images of capsules with magnetite nanoparticles.  
Image of capsules with magnetite nanoparticles is viewed using TEM (top). Capsules with 
magnetite nanoparticles without (bottom left) and with (bottom right) a magnet. TEM image 




7 Deliver capsules with magnetite nanoparticles to 
epithelial cells with physical method 
Epithelium is one of the four basic types of animal tissue with functions of 
secretion, selective absorption, protection, trans-cellular transport and 
detection of sensation. As mentioned before, epithelial cells form continuous 
sheets by junction complex like tight junctions, desmosomes, adhering 
junctions and gap junctions. Thus, epithelial cells are very concentrated 
connect with each other like bricks in a wall result a very narrow intercellular 
space.  
One primary function of epithelial cells is protection. As these cells cover 
and line all free body surfaces, create barriers between outside environment 
and the body. Stratified epithelial cells provide better protection of the 
underlying tissue even the outmost layer cells is damaged. The most 
interesting function of epithelial cells in drug delivery system is transportation. 
Epithelial cells of intestinal lining are able to transport filtered substances by 
active transport system which moves molecules across cell membrane 
against its concentration gradient.  
In order to transfer materials between two different environments and 
maintain distinct properties on both sides of the cell, transcytosis is 
selectively transport of membrane bounded carrier contains materials from 
apical surface of the cell to basolateral surface. This transportation is for 
small molecules and macromolecular in nanometer range. For 4 μm diameter 
polyelectrolyte capsules, the internalization mechanism is unknown yet, but 
endocytosis is considered as the most possible reason.     
  The epithelial cell used in this study is Caco-2 cell line which is a 
continuous cell of heterogeneous human epithelial colorectal 
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adenocarcinoma cells. This cell line is able to form a confluent monolayer on 
cell culture. The monolayer contains epithelial cell with cylindrical polarized 
morphology, microvilli on the apical side, and tight junctions between 
adjacent cells. It performs as a physical and biochemical barrier which blocks 
ions and small molecules pass the layer (Artursson 1990). The Caco-2 cell 
line is also widely used in drug delivery studies as an in vitro model of the 
human small intestinal mucosa to investigate the absorption of drugs.  
Magnetite nanoparticles in a carrier are able to provide external force with 
magnetic fields. The magnet can be placed on desired area of the sample. 
Thus microcapsules loaded with magnetite nanoparticles are manipulated by 
magnet in the area and perform a target delivery. The delivery of magnetite 
nanoparticles loaded carrier systems by applying a magnetic field has been 
performed in vivo (Pankhurst, Connolly et al. 2003). 
7.1 Model of co-incubation of capsules with magnetite 
nanoparticles and epithelial cells 
The monolayer of epithelial cells is provided by Dr. Maya Thanou in 
pharmacy department of King's College London. Capsules with magnetite 
nanoparticles used in this study is 8 layers biodegradable DS/PLL-FITC 
capsules with magnetite nanoparticles between 4th and 5th layer. Capsules 
formation is (Dextran sulfate/ Poly L lysine – FITC)2/ Fe3O4/ (Dextran sulfate/ 
Poly L lysine – FITC)2, and control capsules formation is (DS/PLL-FITC)4. 
Figure 7.1 shows capsules with magnetite nanoparticles incubate with 
epithelial cells with a magnet at the bottom. 
Most cancer cells and immune cells such as macrophages and dendritic 
cells are called phagocytic cells. Many researches proved these cells are 
able to internalize polyelectrolyte microcapsules. Caco-2 cells are colon 
cancer epithelia cells, also internalize capsules spontaneously. 
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Microcapsules internalized by breast cancer cells of the cell line MDA MB 
435s has been demonstrated by Sukhorukov et al in 2005. They found 
approximate 70 % and 90 % of the breast cancer cells are able to adhering 
microcapsules within 1 and 3 hours, respectively. (Sukhorukov, Rogach et al. 
2005).  
 
Figure 7.1: Schematic illustration of physical stimuli of capsules with magnetite nanoparticles 
and epithelial cells. 
Capsules with magnetite nanoparticles incubate with epithelial cells with a magnet at the 
bottom. 
Therefore, even no magnetic field applying during capsules and Caco-2 
cells co-incubation, both capsules with magnetite nanoparticles and control 
capsules are adhered by most of the cancer cells after 1 hour. Thus, to 
minimize the affect caused by cancer cells natural absorption, and observer 
difference between samples of capsules with magnetite nanoparticles and 
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control capsules with Caco-2 cells, the co-incubation time is reduced from 
hours to few minutes.     
7.2 CLSM study on capsules with magnetite nanoparticles 
and epithelial cells co-incubation 
Same volume of capsules with magnetite nanoparticles and control 
capsules were premixed with same volume of culture medium in two tubes. 
Then the tubes of culture medium were added to the different wells with 
Caco-2 cells. A magnet was placed under the wells to generate magnetic field 
during co-incubation time. After 5 minutes, both samples were removed from 
the magnet and washed 3 times with culture medium to remove un-adhered 
capsules.  
Caco-2 cells were stained with 4', 6 - diamidino - 2 - phenylindole (DAPI) at 
the concentration of 50 μg / ml, a nuclear stain, for 10 minutes at room 
temperature. After nucleus staining, cells were gently washed with culture 
medium and observed using CLSM. Images are taken together with Dr. Maya 
Thanou group (pharmacy department of King's College London). 
  In Figure 7.2, the co-incubation time for capsules with magnetite 
nanoparticles (A) and control capsules (B) with Caco-2 cells is 5 minutes. 
Both images show capsules (labeled with FITC) are adhered by the cells. 
From the enface images, the number of adhered capsules with magnetite 
nanoparticles is obviously more than control capsules. In bottom and right 
side panels at z – axis, most of capsules are located at the top of the cells. 
However, some of the capsules with magnetite nanoparticles are at the 





Figure 7.2: Capsules with epithelial cells after treated with magnet for 5 minutes. 
Image (A) is capsules with magnetite nanoparticles, and image (B) is control capsules. The 
main panel shows the enface image at a given z-depth. The bottom and side panels show 
the x–z and y–z cross-sectional images, respectively.  
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 All three dimensional CLSM images of epithelial cells are taken from the 
glass slide to the top of the cell at a series of depths with Δ z = 250 nm 
interval along the z - axis. The main enface panel shows the fluorescent 
image in the x – y cross section at a given z – location. The two smaller 
panels reveal the structure of the Caco-2 cells along the x – z at the bottom 
panel and y – z cross sections at the right side panel as indicated by dashed 
lines in the enface image. 
Same method was using on capsules with magnetite nanoparticles and 
control capsules with Caco-2 cells treated by magnet for 10 minutes. Images 
(A) and (B) in Figure 7.3 show capsules with magnetite nanoparticles and 
control sample, respectively. The number of both capsules in Figure 7.3 is 
higher than in Figure 7.2. Long time of co-incubation of capsules / cells is 
increasing the number of adhered capsules. 
The simple, squamous epithelial cells are quite distinctive morphologically. 
They are extremely thin (~ 0.2 – 0.5 μm) in the regions not including nuclei 
(TUMA and HUBBARD 2003). Due to limitation of cell thickness, no enough 
space in the cell to internalize aggregated capsules. In both Figure 7.2 and 
Figure 7.3, capsules with magnetite nanoparticles are more aggregated than 
controls. The magnetic field generated by the magnet is not homogeneous. 
Thus, some areas of the cells were treated with a strong magnetic field while 
other areas are treated with a weak one. One reason for capsules 
aggregation is many capsules with magnetite nanoparticles are attracted by 





Figure 7.3: Capsules with Caco-2 cells after treated with magnet for 10 minutes. 
(A) Capsules with magnetite nanoparticles and (B) control capsules. The main panel shows 
the enface image at a given z-depth. The bottom and side panels show the x–z and y–z 
cross-sectional images, respectively. 
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In both Figure 7.2 and 7.3, all capsules are close to the cell nucleus rather 
than the cell edges. Because the nuclei is the highest part of the cell, and the 
edge is too thin to internalize capsules with 4 μm diameter. The number of 
adhered capsules pre cell is summarized in Figure 7.4. 
7.3 Number of adhered capsules per epithelial cell 
Figure 7.4 shows the number of adhered capsules in 5 minutes and 10 
minutes samples. The number of adhered capsules in capsules with 
magnetite nanoparticles with Caco-2 cells sample is 3 times higher than the 
control sample. As previous work on microcapsules with breast cancer cells, 
after 1 hour co-incubation of microcapsules and breast cancer cells, the 
number of internalized capsules per cell is around 1.4 (Sukhorukov, Rogach 
et al. 2005).  
Number of adhered capsules in 10 minutes sample is ~1.5 times higher 
than 5 minutes samples. The magnet provides additional driving force 
attracts the capsules with magnetite nanoparticles to the bottom of the well. 
These capsules with magnetite nanoparticles may aggressively pass through 
extracellular matrix and cell membrane by damage the cells surface. 
Internalization of microcapsules by cells is one of primary processes for 
monitoring intracellular cargo transportation. Although internalization 
mechanism is unknown yet, phagocytosis is mostly accepting reason of these 




Figure 7.4: Number of adhered capsules per cell. 
Every point in the results was based on 5 experimental data from five independent 
experiments, although, every experimental data was the averaged value based on 20 cells. 
7.4 Conclusion 
  In this study, we demonstrate the colon cancer epithelia cells of Caco-2 
internalize certain amount of capsules in few minutes. Control capsules 
naturally precipitate on the top of the epithelial cells. Capsules with magnetite 
nanoparticles are attracted by additional magnetic field to the cells. The 
additional driving force makes the capsules internalization more efficiency. 
The result is shown in our work that 1.2 and 1.8 adhered capsules per cell are 
observed for treat the sample at 5 and 10 minutes with magnet respectively. 
These numbers of capsules is 3 times higher than the control samples. 
Furthermore, capsules with magnetite nanoparticles are more aggregated 
and close to the cell bottom.  
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For further studies, to prove the capsules locate inside the cells, cell 
membrane is labeled. Another significance of this study is the magnet can be 
placed in any directions such as side or top of vessels. The magnetically 
forced uptake of capsules model is able to play an important role in vivo, as 
the blood circulation takes capsules anywhere within the body, but the highly 
forced magnetic field is able to force the capsules with magnetite 




8 Investigation of interactions between capsules and 
endothelial cells by biochemical stimuli 
The luminal surface of blood vessels is lined by a monolayer of endothelial 
cells, which are in direct contact with the circulating blood. The vascular 
endothelial cells play significant roles in tissue homeostasis, vascular 
regulation, blood cell activation and migration during physiological and 
pathological processes (Risau 1995; Middleton, Neil et al. 1997). On the 
luminal surface of endothelial cells, the glycocalyx has a brush like structure 
that contains negatively charged matrix of proteoglycans, 
glycosaminoglycans and glycoproteins (Pries, Secomb et al. 2000). The 
thickness of the glycocalyx layer ranges between a few hundred nm and few 
μm (Squire, Chew et al. 2001). Neuraminidase, an enzyme that cleaves 
N-acetyl neuraminic acid residues of glycoproteins and targets specifically 
the sialic acid component of the endothelial glycocalyx is commonly used to 
manipulate the structure of the glycocalyx (Barker, Konopatskaya et al. 
2004).   
Recently, number of natural polyelectrolytes and polypeptides have been 
used to fabricate biodegradable microcapsules and these capsules are 
successfully internalized by several phagocytic cells such as most cancer 
cells and immune cells (Sukhorukov, Rogach et al. 2005; De Geest, 
Vandenbroucke et al. 2006). The mechanisms of uptake of microcapsules by 
living cells are not yet fully understood (De Cock, De Koker et al. 2010) and 
are still under investigation, but apparently the natural endocytosis of these 
cells is most probable reason for uptake. So far, no reports on microcapsules 
internalization and/or degradation by non-phagocytic cells had been 
published. In this paper, normal healthy cells of human umbilical vein 




This part of thesis is to investigate the role of the glycocalyx on 
trans-membrane movement of microcapsules in vitro. Microcapsules with 
neuraminidase and CaCO3 co-precipitated templates were fabricated. The 
neuraminidase encapsulation efficiency and release rate were investigated. 
Comparison between neuraminidase loaded microcapsules and the control 
was carried out. We further studied the degradation rate of DS/PArg 
microcapsules after internalized by HUVECs. 
8.1 Capsules charge affected by culture medium 
  In our study, microcapsules were premixed with culture medium and 
incubated with HUVECs, so it is likely that the charge on microcapsule 
outermost layer will be changed by the culture medium due to salt effects and 
protein adsorption. To study this effect, 4 layered PSS – PAH capsules with 
either PSS outmost layer or PAH outmost layer, i.e. (PSS-PAH)2 and 
(PAH-PSS)2 capsules, were mixed with culture medium for 12 hours and 
washed 3 times with Milli-Q water, before their zeta potentials were 
measured.  
Figure 8.1 shows the results and their comparison to the control, i.e. before 
they were exposed to the cell culture medium. It is seen that for the control, 
zeta potentials for PAH and PSS outmost layered capsules are of +10.13 mV 
and -17 mV respectively. However, after 12 hours in the culture medium, their 
Zeta potentials have changed to -5.5 mV and -8.97 mV. Results show that 
sespite their initial difference in the charge property, both capsules exhibited 




Figure 8.1: Zeta potentials of capsules affected by culture medium. 
Zeta potentials of 4 layered PSS – PAH microcapsules with either PAH or PSS outmost layer 
after 12 hours in the cell culture medium (n = 5). 
Cell culture medium contains a variety of components and growth factors 
for cells viability that can alter the charge property of the capsule, including 
salts, such as NaCl (6800 mg/L), KCl (400 mg/L) and NaHCO3 (2200 mg/L). 
Georgieva et al studied the influence of different salts on polyelectrolyte 
hollow microcapsules. They reported that the surface charge of capsules 
changed from initially positive to negative values after 24 hours of incubation 
in each of the carbonate solutions (Georgieva, Dimova et al. 2005). They 
demonstrated that the complete charge reversal of PAH layer is caused by 




8.2 Microcapsules sterilization  
One of the primary problems of study microcapsules for drug delivery to 
living cells is toxicity. After capsules fabrication, an autoclaving step was 
applied for sterilization of capsules. Capsules solution was placed into a 
glass tube with unsealed cover, heated to 126 oC for 30 minutes. After the 
solution cool to room temperature, the capsules were sterilized and ready for 
endothelial cells co-incubation. Thus, the viability of cells is only affected by 
materials of the capsules.  







Figure 8.2: CLSM and SEM images of capsules before and after autoclaving.  
Images from top to bottom are overview CLSM images, zoomed CLSM images, FITC 
intensity along the marked green line, and SEM images represent the capsules before (left) 
and after (right) autoclaving.  
Figure 8.2 shows the initial 4 μm (PSS/PAH)3 capsules collapse during 
drying to flat creased structures. The shell with thickness approximate 20 nm 
was not stable enough to keep the spherical shape of capsule in the dried 
state. Figure 8.2 shows the capsules keep their spherical shape after 
autoclaving, no deformations indicating a collapse were observed. Capsules 
size reduced from average 4 μm to 2 μm with surface became smoother, 
shell thickness was increased and encapsulated fluorescence dye was 
concentrated. The increasing mechanical stability against collapse of the 










Figure 8.3: SEM images of sterilized PSS/PAH microcapsules with endothelial cells. 
Capsules and cells were in the incubator with cells favorite conditions after 2 (A), 4 (B), 7 (C) 
and 14 (D) days.  
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Before adding capsules into cells, capsules were diluted with cell culture 
medium. Number of capsules to cells ratio is 50:1. The culture medium was 
changed every two days during co-incubation. Therefore, the capsules in 
Figure 8.3 (D) were washed at least 6 times with culture medium. From 
Figure 8.3, the cells number is changed, old cells were died and new cells 
were divided. For some cells in Figure 8.2 (B), (C) and (D), large number of 
capsules form aggregates around cell nucleus, and capsules are covered by 
wax like materials, may be inter- or extra-cellular matrix. 
Generally, the PSS/PAH capsules located on HUVECs are non-toxic for 
endothelial cells and cannot be degraded after two weeks. Endothelial cells 
can still survival with many capsules on the membrane l. So far, we can 
conclude these capsules can be adhered tightly by endothelial cells. 
8.3 Encapsulation efficiency of TRICT-dextran 
  Encapsulation efficiency was measured with encapsulated TRICT-dextran 
by PerkinElmer LS55 fluorescence spectroscopy. A process of preloading 
was used for TRICT-dextran encapsulation. 2 mg of TRICT-dextran was 
mixed with 1 ml of 0.33 M CaCl2 and 1 ml of 0.33 M Na2CO3 aqueous 
solutions under vigorous agitation for 15 s. After 3 times wash step with 
Milli-water, CaCO3 micro particles containing TRITC-dextran in their pores 
was used as template for capsules fabrication. The capsules were 
synthesized under typical LbL process, template cores were dissolved while 






Capsules with CaCO3 core Capsules without CaCO3 core 
  
  
Figure 8.4: CLSM images of capsules contain TRICT-dextran 
Images present TRICT-dextran in capsules before (left) and after (right) CaCO3 core 
dissolution. The bottom is the intensity along the green drawing line through the capsules. 
Scale bar is 5 μm. 
Supernatants centrifuged by core dissolution and washings steps, were 
collected for fluorescence spectroscopy measurement. The amount of 
TRITC-dextran encapsulated is mostly depended by the interaction between 
it and CaCO3 in co-precipitation step. Figure 8.4 shows TRITC-dextran 
intensity of capsules interior is obviously reduced after core dissolution. 
Therefore, the encapsulated protein is rapidly released in CaCO3 template 




Control TRITC-dextran intensities with different prepared concentrations 
have been measured to generate the calibration curve. Once the calibration 
curve is generated, any samples with the same substance at the same 
wavelength can be calculated from the slope. The amount of TRITC-dextran 
lost during capsules fabrication in washing steps is very lower compare with 
core dissolution step. The amount of protein lost during core removing step is 
varied from 30% to 40% of the total amount of protein. More polyelectrolyte 
layers result thicker capsule shell which could keep more proteins compared 
with few layers capsules in core dissolution step. Encapsulation efficiency of 
neuraminidase enzyme used in the following section is tested.  
8.4 Encapsulation efficiency and release rate of 
neuraminidase  
Polyelectrolyte capsules are not completely sealed for proteins. Protein 
release occurs according to capsule wall composition (She, Wang et al. 
2012). In our study, microcapsules, (PSS/PAH)2, had 4 layers. 4 mg of 
neuraminidase was co-precipitate with CaCO3 microparticles. 0.836 mg of 
neuraminidase remained in the glass beaker with uncollected particles. 
During polyelectrolytes absorbing and capsule washing steps, there was 
negligible amount of neuraminidase losses, and its concentration in the 
supernatants was too low to be detected by UV−Vis Spectroscopy. 1.56 mg 
of neuraminidase was lost in the CaCO3 template decomposition step, called 
burst release. Therefore, approximately 21% and 39% of the neuraminidase 
were lost in the core co-precipitation and the dissolution steps respectively, 
leaving 40% of the neuraminidase in capsules. Total number of capsules was 
determined using haemocytometer counting chambers, and they were 
estimated to be (7.8 ± 0.3) ×107. The amount of neuraminidase in a single 
microcapsule was therefore estimated to be ~20 pico-gram.   
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To investigate the release rate of neuraminidase from (PSS/PAH)2 
microcapsules, all microcapsules were placed in 2 ml Milli-Q water at room 
temperature. The supernatant was collected after 2, 24 and 72 hrs, and the 
surrounding water was fully refreshed at each time point. The concentration 
of neuraminidase in the collected supernatant was determined by UV-Vis 
spectrometer. Figure 8.5 shows the release rates of neuraminidase from 
(PSS/PAH)2 microcapsules. It is seen that in the first 2 hours, neuraminidase 
was released at 12.82 μg/h, but the value decreased to 10.36 μg/h over the 
next 22 hours and then to 8.64 μg/h over the following 48 hours. Protein 
encapsulation and release have been studied by a number of groups (Antipov, 
Sukhorukov et al. 2001; De Geest, Sanders et al. 2007; She, Antipina et al. 
2010). Our results are consistent to their findings that the release rate of 
proteins from polyelectrolyte microcapsules over the first hours is significantly 
higher than that over the following hours. 
 
Figure 8.5: Neuraminidase release rate.  
Release rate from (PSS/PAH)2 microcapsules at room temperature (number of experiments, 
n = 5). 
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8.5 Samples preparation 
Capsules preparation is introduced in the above section of chapter 6. 
HUVECs (primary pooled) were purchased from Lonza (Lonza Cologne AG, 
Germany). They were thawed and cultured in the M199 medium (Gibco) in 
collagen type I-coated flasks (5 μg/ml) at 37 oC and 5% CO2. The culture 
medium contains 10 % foetal bovine serum, EC growth factor-β (1 ng/ml), EC 
growth supplement from bovine neural extract (3 μg/ml), thymidine (1.25 
μg/ml), heparin (10 μg/ml), 100 U/ml penicillin, 100 mg/ml streptomycin (all 
supplements are from Sigma Aldrich). The medium was changed every 2 
days. After reaching 80% confluence, HUVECs were treated with 0.25% 
trypsin containing 0.02% ethylenediaminetetraacetic acid (EDTA; Sigma 
Aldrich) and cells were split and seeded on collagen type I-coated glass slide. 
(Bai and Wang 2012).  
8.6 Cleavage of the glycocalyx by neuraminidase 
The process of a neuraminidase loaded microcapsule entering a vascular 
endothelial cell is represented in a schematic drawing in Figure 8.6. Figure 
8.6 (A) shows microcapsule is added in culture medium and incubated with 
endothelial cells; Figure 8.6 (B) shows capsule comes to contact with the 
endothelial membrane. Neuraminidase released from the capsule cleaves 
the endothelial glycocalyx; Figure 8.6 (C) shows capsule is internalized by 






Figure 8.6: Schematic illustration of the uptake of a neuraminidase-loaded microcapsule by a 
vascular endothelial cell. 
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HUVECs on cover slips were stained as following: wheat germ agglutinin 
(WGA-FITC) was used to bind to N-acetly-D-glucosamine and sialic acid 
component of the glycocalyx; the endothelial cytoplasm was stained by Cell 
Tracker Red CMTPX and cell nucleuses were stained using Hoechst 33342. 
Samples were briefly washed 3 times using the serum free M199 medium 
before each staining step. WGA-FITC and Cell Tracker Red were applied to 
live cells for 15 min at 37 oC before Hoechst 33342 was applied for 10 min. 
Cells were washed and immersed in culture medium contain 10% serum 
immediately after staining, and were kept in the culture medium with serum 
during CLSM observation. 
For neuraminidase treated samples, they were prepared according to the 
protocol by Barker et al (Barker, Konopatskaya et al. 2004) as we performed 
in previous studies (Bai and Wang 2012; Bai and Wang 2013). HUVECs 
samples were gently washed with serum free M199 medium twice before 
they were incubated with 1 mg/ml neuraminidase medium for 10 min at 37 oC. 
They were then stained and observed under the CLSM. 
Different enzymes are able to cleave different components of the 
glycocalyx. The technique and protocol of enzyme treatments have been 
studied in a number of previous investigations (Barker, Konopatskaya et al. 
2004). In this work, we first establish that neuraminidase abolishes the 
glycocalyx layer on our cultured endothelial cells. Then we investigate 
interaction between microcapsules and HUVECs with and without the 
glycocalyx layer. Finally, we study interaction between neuraminidase-loaded 






Figure 8.7: Three dimensional CLSM images of HUVECs.  
(A) Control, (B) Neuraminidase treated. The main panel shows the enface image at a given 
z-depth. The bottom and side panels show the x–z and y–z cross-sectional images, 
respectively. Scale bar in the main panel = 10 µm, and scale bar in the bottom and side 
panels = 8 µm. 
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Figure 8.7 shows the three dimensional CLSM images of HUVECs from 
the glass slide to the top of the cell at a series of depths along the z-axis, with 
Δz = 250 nm. The main enface panel shows the fluorescent image in the x–y 
cross section at a given z-location. The two smaller panels reveal the 
structure along the x–z (bottom panel) and y–z cross sections (right side 
panel) as indicated by dashed lines in the enface image. Figure 8.7 (A) is the 
control, where HUVECs have been cultured for 14 days. The green-stained 
glycocalyx layer is seen to have a thickness of several hundred nanometers 
to one micrometer. It is continuous and covers the surface of the endothelium. 
Following neuraminidase treatment, shown in Figure 8.7 (B), there is hardly 
any green fluorescence in the image; giving evidence that neuraminidase 
cleaves away most of the glycocalyx layer from the HUVEC membrane. 
Figure 8.8 shows the interaction between microcapsules and endothelial 
cells.  Cell-viability assays in vitro such as MTT test reported no acute cell 
toxicity at moderate microcapsule concentrations (An, Kavanoor et al. 2009). 
In all our study, the ratio between the numbers of microcapsules and 
HUVECs was controlled at approximately 20:1. Further increase of the 
microcapsule concentration in the culture medium results in more capsules 
precipitated on the cell surface, which may affect cell metabolism and viability 
(Kirchner, Javier et al. 2005; Liu, Gao et al. 2005). 
For the Control, shown in Figure 8.8 (A), HUVECs were cultured for 14 
days and their membrane was covered with the glycocalyx layer. (PSS/PAH)2 
microcapsules with TRITC-dextran (hence red fluorescence in images) was 
added in the culture medium. Following 48 hours co-incubation, there were a 
small number of microcapsules observed in the enface image. However, a 
close look of the bottom and side panels in Figure 8.8 (A) revealed that these 
microcapsules were all on top of the endothelial glycocalyx and none had 








Figure 8.8: Interaction between microcapsules and endothelial cells.  
(A) Control, (B) Endothelial cells were pretreated with neuraminidase and then incubated 
with microcapsules for 48 hrs, (C) Enlarged image of the highlighted area in B). The main 
panel shows the enface image at a given z-depth. The bottom and side panels show the x–z 
and y–z cross-sectional images, respectively. 
In Figure 8.8 (B), HUVECs were pretreated with 1 mg/ml neuraminidase for 
10 min at 37 oC. This abolished the glycocalyx layer on the cell membrane. 
(PSS/PAH)2 microcapsules were added to the culture medium and incubated 
with the pretreated HUVECs for 48 hours. At the end of 48 hours, part of the 
glycocalyx layer was recovered, but it was still patchy with little sign of green 
staining on the membrane above the cell nucleus. Microcapsules were 
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observed inside the endothelial cells. This can be seen clearer in the 
enlarged image in Figure 8.8 (C), where red stained microcapsules clustered 
around cell nucleus. They were inside the cells and, in places, covered by 
re-grown glycocalyx layer. The x-z and y-z panels revealed that they leveled 
with the nucleus rather than being on top of the cell membrane, as seen in 
the control. 
8.7 Number of capsules adhered by HUVECs 
 (PSS/PAH)2 microcapsules were fabricated with neuraminidase as 
described before. They were divided equally into 20 portions and added to 
HUVECs with 2 ml culture medium. The number of microcapsules in each 
sample was estimated in the haemocytometer counting chamber. After 2 
hours co-incubation, the sample was washed 3 times with the culture medium. 
The number of microcapsules in the supernatant was estimated by the 
haemocytometer counting chamber.  
 total number of 




number of capsules 




% of capsules 
entered or adhered 
to HUVECs 
Control 4.07 ± 0.08 3.88 ± 0.21 4.67% 
Neuraminidase 
loaded capsules 
3.93 ± 0.11 2.76 ± 0.17 29.77% 
Table 8.1: number of capsules before and after co-incubated with HUVECs. 
Neuraminidase-loaded microcapsules show a significantly increase in the number that 
adhere to or enter vascular endothelial cells after 2 hours in the cell culture medium (number 
of experiments, n = 20).  
As the control, similar experiments were carried out for (PSS/PAH)2 
microcapsules without neuraminidase. Table 8.1 shows our data from 
experiments. For the control, most of the microcapsules were washed away, 
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and only ~5% remained in the sample. For neuraminidase-loaded 
microcapsules, there were significant increases and approximately 30% of 
microcapsules had either adhered to or entered into vascular endothelial 
cells. In the following study, CLSM images will be used to reveal the location 
of these microcapsules in relation to HUVECs. 
8.8 Interaction between neuraminidase-loaded microcapsules 
and endothelial cells  
During immuno-fluorescent staining steps, cultured HUVECs were briefly 
washed using the serum free M199 medium for 9 times before observed by 
CLSM. All microcapsules suspended in the medium should be removed. 
Three-dimensional CLSM images are taken from the glass slide to the top of 
the cell.  
In Figure 8.9, the location of the microcapsules in relation to endothelial 
cells was observed after they were added in the cell culture medium. In the 
control group, shown in Figure 8.9 (A), there were far fewer capsules in the 
enface image, as most of the microcapsules were washed away. The bottom 
and side panels in Figure 8.9 (A) revealed that the remaining capsules (red) 
were located on the glycocalyx layer (green) outside of the endothelial cells. 
In contrast, for neuraminidase loaded microcapsules, shown in Figure 8.9 (B), 
there were clusters of capsules near the cell nucleus in the enface image. 
From the bottom and side panels, we can see the capsules were inside the 
endothelial cell and existed at the same z - level as the nucleus. The 





Figure 8.9: Interaction between (PSS/PAH)2 capsules and HUVECs after microcapsules 
were added in the culture medium for 2 hours.  
(A) Control capsules, (B) neuraminidase-loaded microcapsules. The main panel shows the 
enface image at a given z-depth. The bottom and side panels show the x–z and y–z 
cross-sectional images, respectively.  
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Note the difference between Figure 8.9 (B) and Figure 8.8 (C). Although in 
both studies, microcapsules were able to enter the endothelial cells, in Figure 
8.8 (C), endothelial cells were pretreated with neuraminidase to abolish their 
entire glycocalyx layer. The green stain represented the newly synthesized 
glycocaly after 48 hours culture. In Figure 8.9 (B), neuraminidase loaded 
microcapsules came to contact with the glycocalyx layer, cleaved the 
glycocalyx structure in their proximity and left most of the glycocalyx layer 
intact, hence the green stained glycocalyx layer in Figure 8.9 (B) was well 
developed. 
PSS/PAH/GNPs/PSS/PAH capsules contain neuraminidase in the cavity 
were used for SEM with FIB investigation. The capsules were incubated with 
endothelial cells for 2 hours. After co-incubation, the sample was fixed by 
immersed with 5% formaldehyde for 10 minutes and then washed with PBS 
buffer. After sample fixation, dehydration step was applied. Dehydration 
process was followed by sequentially wash the cell samples in methanol with 
increased concentrations at 20%, 40% and 60% for 5 minutes, 80% for 3 
minutes, and 100 % methanol for 30 seconds. After the methanol removing, 
the samples were left in dry seal vacuum desiccator with calcium chloride 
anhydrous overnight. 
Sample of SEM images in Figure 8.10 is tilted. Angles between the sample 
and horizontal plane, electron detectors, ion beam are 52o, 38o and 90o. The 
milled part is 8 μm in length, 1 μm in width and 3 μm in depth. The milled part 
should reach the glass slide, and shows cuboid shape. But during the milling 
process, the sample was drifted result the final shape uncontrolled. However, 








Figure 8.10: SEM with FIB images of capsule in endothelial cell. 
(A) is overview of a HUVEC with a capsule; (A) and (B) are images viewed by 
Everhart-Thornley detector (ETD); (C) is viewed by back scattered electron detector (BSED). 
(B) and (C) is the area marked in A) after milling by focused ion beam, bright dots in (C) are 
GNPs.  
Because HUVECs lost all the water in dry state, its thickness significantly 
drops from average 3 - 5 μm to 1 – 2 μm (even lower in the parts without 
nuclei). Thus, it is easier to observe the cross section and interface of the 
sample for single capsule in a cell. More capsules in one cell makes the 
interface between cell membrane and capsule shell too thin to be observed.   
In Figure 8.10 (A), the cell is in dried state, a nucleus in the center of cell is 
still higher than the edges. The marked area in Figure 8.10 (A) is the milled 
part shows in Figure 8.10 (B) and (C). GNPs are shows in BSED image (C) of 
Figure 8.10. The GNPs prove the capsule within the milled part. In the cross 
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section of image Figure 8.10 (B), the top left shell of the capsule is definitely 
below the cell membrane. As the height of capsule increase from left to right 
side, the capsule’s top shell beneath the cell membrane.   
The bottom shell of the capsule closes to the glass slide which is a bright 
area with diamond shape in Figure 8.10 (B) and (C). In Figure 8.10 (C), the 
GNPs in the cross section were directly scanned by the detector and shows 
bright white colour; while GNPs on the top shell of the capsule are covered by 
cell membrane and shows gray colour.  
  Therefore, capsules functionalized with neuraminidase are able to cleave 
part of glycocalyx layer on the HUVECs membrane. After the glycocalyx is 
removed, channels that allowing the passage of capsules through the cell 
membrane becomes accessible. Three-dimensional CLSM images reveal 
that microcapsules containing neuraminidase are internalized by HUVECs, 






8.9 Effects of time on the internalization of neuraminidase 
loaded microcapsules  
  Time required for microcapsules to pass through the cell membrane is very 
important in drug delivery. In the following study, we investigate the uptake of 
neuraminidase loaded (PSS/PAH)2 microcapsules by HUVECs at different 
time. In Figure 8.11, CLSM images of capsules in HUVEC samples at 0.5, 1, 
2, and 3 hours are shown. Equal amount of capsules were added in samples 
at the beginning of experiment.  
At t = 0.5 hour, shown in Figure 8.11 (A), a number of microcapsules 
adhere to endothelial cells. Majority of these capsules were still above the 
glycocalyx layer, although a few has entered into the cells. In Figure 8.11 (B), 
at t = 1 hour, more capsules have made their way through the membrane into 
the cell. However, there were still many microcapsules above the endothelial 
glycocalyx layer. In Figure 8.11 (C), at t = 2 hours, most capsules have 
passed through the cell membrane with only a few capsules outside the cell. 
Finally, in Figure 8.11 (D), at t = 3 hours, we observe a similar pattern as that 
in t = 2 hours sample, without further significant change.  
These results suggest that the approximate time for HUVECs to internalize 
neuraminidase-loaded (PSS/PAH)2 microcapsules is approximately 2 hours. 
This time will clearly be affected by the permeability of the capsules and the 







Figure 8.11: CLSM images of neuraminidase-loaded (PSS/PAH)2 microcapsules in HUVEC 
samples at different time points.  
(A) t = 0.5 hour; (B) t = 1 hour; (C) t = 2 hours and (D) t = 3 hours. The main panel shows the 
enface image at a given z-depth. The bottom and side panels show the x–z and y–z 




Figure 8.12: (PSS/PAH)2 capsules with neuraminidase are incubated with cells after 7 days. 
Culture medium was changed every 2 days. The main panel shows the enface image at a 
given z-depth. The bottom and side panels show the x–z and y–z cross-sectional images, 
respectively. 
  (PSS/PAH)2 capsules are known as non-biodegradable. Stability of 
neuraminidase loaded microcapsules after their internalization by HUVECs 
was investigated in the following study. HUVEC samples containing 
(PSS/PAH)2 capsules in their cytoplasma were cultured for 7 days. At the end 
of day 7, cells showed no difference to the control group, i.e. HUVECs 
cultured for the same length of time without capsules inside. In Figure 8.12, 
we can see that (PSS/PAH)2 capsules retained their circular shape and 
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integrity. The capsules remained in cytoplasm, which can be seen in the 
bottom and side panels. 
8.10 Neuraminidase loaded biodegradable DS/PArg capsules 
Although (PSS/PAH)2 microcapsules have excellent biocompatibility and 
can be functionalized with neuraminidase to enter vascular endothelial cells, 
they are not biodegradable. In drug delivery systems for therapeutic 
purposes and medical applications, the drug carrier needs not only be 
biocompatible but also biodegradable over a reasonable period of time under 
physiological conditions. Polyelectrolytes microcapsules made of natural 
polysaccharides and polypeptides are known to be biodegradable, and once 
in phagocytic cells, they can degrade within hours (Rivera-Gil, De Koker et al. 
2009).  
De Geest et al developed polyelectrolyte microcapsules that could be 
degraded by intracellular proteases or hydrolytic enzymes (De Geest, 
Vandenbroucke et al. 2006). The dextran sulfate/poly-L-arginine (DS/PArg) 
microcapsules were susceptible to enzymatic degradation and gradual 
disintegrated over 60 hours after internalized by VERO-1 cancer cells. De 
Koker reported these microcapsules could also be degraded after incubated 
with bone-marrow-derived dendritic cells, and proposed macro-pinocytosis 
as the mechanism of uptake of capsules by the cells (De Koker, De Geest et 
al. 2007; De Koker, De Geest et al. 2009). Here we use the same 
composition to make (DS/PArg)2 microcapsules and explore the capsule fate 







Figure 8.13: Interaction between (DS/PArg)2 microcapsules and HUVECs after 48 hours 
co-incubation.. 
(A) Control, capsules were seen on top of the glycocalyx layer, (B) Endothelial cells were 
pretreated with neuraminidase, and capsules were seen inside the cells clustered 
around the nucleus, (C) zoomed in view of the area highlighted in (B). The main panel 
shows the enface image at a given z-depth. The bottom and side panels show the x–z 
and y–z cross-sectional images respectively.  
Same experiments presented above on (PSS/PAH)2 microcapsules were 
carried out on biodegradable (DS/PArg)2 microcapsules. Firstly, we establish 
the interaction between (DS/PArg)2 microcapsules and HUVECs with and 
without the glycocalyx layer. Figure 8.13 shows the results after (DS/PArg)2 
microcapsules were added in HUVEC samples for 48 hours. For the control 
group, in Figure 8.13 (A), HUVECs have a well-developed glycocalyx layer, 
and (DS/PArg)2 microcapsules are observed on top of the glycocalyx outside 
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the endothelial cells. For neuraminidase pretreated HUVECs, in Figure 8.13 
(B), clusters of (DS/PArg)2 microcapsules were observed near nucleus of 
endothelial cells. The green stain represents newly synthesized glycocalyx in 
the 48 hour period. The bottom and side panels reveal these microcapsules 
are at the same z- location as the nucleus of the cell, and in places, they were 
underneath the glycocalyx layer. A close up view is presented in Figure 8.13 
(C), where the location of the microcapsules inside the endothelial cells can 
be seen more clearly. 
Internalization of neuraminidase loaded (DS/PArg)2 microcapsules at 
different time points are studied at t = 0.5 hour, 1 hour, 2 hour, and 3 hours. 
As seen in Figure 8.14, the number of internalized microcapsules increases 
with time. By t = 2 hours, there are a large of number of capsules inside 
HUVECs, clustering in cytoplasma around nucleus. As time increases to t = 3 
hours, there is a further increase of capsules inside HUVECs, but the 
increase is less significant. A quantitative measure of the number of capsules 









Figure 8.14: Internalization of neuraminidase-loaded (DS/PArg)2 microcapsules after they 
were added in HUVEC culture medium for different length of time. 
(A) t = 0.5 hour, (B) t = 1 hour, (C) t = 2 hour and (D) t = 3 hours. The main panel shows the 
enface image at a given z-depth. The bottom and side panels show the x–z and y–z 
cross-sectional images respectively. 
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Figure 8.15 shows the relationship between the number of internalized 
capsules and the time after they are added in HUVEC samples. For both 
(PSS/PAH)2 and (DS/PArg)2 capsules, their presence in endothelial cells was 
not uniform. There are cells that take in many capsules, while the neighboring 
cells have few capsules in them.  
 
Figure 8.15: Number of internalized capsules per cell increases with time following their 
addition into HUVEC samples.  
Every point in the results was based on 5 experimental data from five independent 
experiments, although, every experimental data was the averaged value based on 20 cells..  
In our study, we chose two sampling areas randomly in an experiment, with 
approximately 20 cells being examined. The average number of capsules in a 
cell in an experiment is recorded. The experiment was repeated five times for 
each time point. For both (PSS/PAH)2 and (DS/PArg)2 capsules, the number 
inside the cell increases with the time. The increase in number is faster at 
earlier time (i.e. up to t = 1 hour) and slows down after 2 hours. Higher 
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number of biodegradable (DS/PArg)2 capsules are observed in cells than 
(PSS/PAH)2 capsules at all given time points. The results support the 
hypotheses that neuraminidase-loaded microcapsules release the enzyme to 
cleave the glycocalyx in the proximity of the capsules, leading to their 
internalization in vascular endothelial cells.  
8.11 Degradation of (DS/PArg)2 capsules in HUVECs  
Most cancer cells and immune cells are phagocytic cells such as 
macrophages and dendritic cells are able to internalize capsules (De Cock, 
De Koker et al. 2010). In vitro and in vivo studies on cellular uptake of 
capsules and degradable capsules are able to be degraded at physiological 
pH or destroyed by endogenous enzymes have been recently published. 
Polyelectrolyte microcapsules formed by and enzymatically or hydrolytically 
degradable polycation could spontaneously degrade in several types of cell 
(De Geest, Vandenbroucke et al. 2006; De Koker, De Geest et al. 2007; De 
Koker, Naessens et al. 2010).  
To investigate the degradation of (DS/PArg)2 capsules after their 
internalization in HUVECs, we studied samples at different days. Figure 8.16 
shows that (DS/PArg)2 capsules gradually disintegrate between 3 days and 7 
days. After 1 day in endothelial cells, as shown in Figure 8.16 (A), capsules 
retain their circular shape and integrity. By 3 days, some of the capsules start 
to change their shape to discontinuous and patchy circle. By the end of 5 
days, in Figure 8.16 (C), most of the capsules have disintegrated to pieces 
and hardly any intact capsules can be seen inside endothelial cells. By the 
end of 7 days, as seen in Figure 8.16 (D), microcapsules have completely 
degraded into pieces, with the red coloured polyelectrolytes clouds and dots 








Figure 8.16: (DS/PArg)2 microcapsules at different days inside endothelial cells 
(A) 1 day, (B) 3 days, (C) 5 days and (D) 7 days. The main panel shows the enface image at 




Further studies on biodegradable DS/PArg microcapsules contain 
neuraminidase were performed with SEM. Back scattered electron detector w 
used for GNPs loaded DS/PArg capsules imaging. Thus, the formation of 
sample used in SEM studies is DS/PArg/GNPs/DS/PArg with neuraminidase 
in capsules cavity. The GNPs in capsules shell is not affect cell viability and 
interactions between microcapsules and HUVECs.  
Figure 8.17 shows biodegradable DS/PArg capsules with GNPs in the 
shell and neuraminidase in cavity are incubated with endothelial cells after 7 
days. Everhart Thornley detector (ETD) images on the left side, and back 
scattered electron detector (BSED) images on the right side. Figure 8.17 (A) 
shows several capsules are on the top of the cell in region B, while few 
capsules are under the cell membrane in region C. Some of the capsules in 
Figure 8.17 (B) are still have same morphology with SEM image of capsules 
after fabrication. 
Figure 8.17 (C) shows the surface of capsules is smoother than Figure 
8.17 (B). GNPs shows in BSED of Figure 8.17 (B) are brighter and densely 
formed with capsule shape; while in Figure 8.17 (C) are not firmed by capsule 
and diffused in a larger region than capsule size. The cross section in Figure 
8.17 (B) shows capsules partially in the cell, and in Figure 8.17 (C) shows 












Figure 8.17: (DS/PArg)2 capsules with GNPs in the shell and neuraminidase in cavity are 
incubated with endothelial cells after 7 days. 
All images are tilt 52 degree. Images of (B) and (C) are zoomed in part of image (A) after 
focused ion beam etching. Images on the left side were viewed using Everhart Thornley 
detector and on the right side were viewed using back scattered electron detectors. 
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In Figure 8.17, capsules with concentrated GNPs in the shell are 
considered as not degraded, while capsules with GNPs in a widespread area 
are considered as degraded. Some capsules are not internalized by HUVECs 
even with neuraminidase. One possible reason is the space inside the cell is 
occupied by internalized capsules, and no enough space for other capsules. 
Also neuraminidase encapsulation cannot make sure each capsule contain 
certain amount of enzyme with working concentration. However, SEM images 
serve as another evidence to insure the neuraminidase capsules are able to 
pass through the HUVECs membrane, and not significantly affect the cell 




8.12 Transfection of HUVECs with neuraminidase loaded 
microcapsules 
  The process of delivery nucleic acids into cells is called transfection. A 
successful transfection of eukaryotic cells requires transient holes opening in 
the cell membrane, and transfers the carried cargo inside. Usually, 
transfection is performed by non-viral methods and cells are eukaryotic. DNA 
can be delivered into the cell nucleus either using physical process or 
designed carriers that deliver the genes into the cells and generate 
expression of the gene (Azzam and Domb 2004). Generally, eukaryotic cells 
can be transfected by three common methods which are physical, viral, and 
chemical methods.  
Some physical methods are more toxic for several kinds of cells and 
always under certain conditions and carried by specialized equipment 
(Villemejane and Mir 2009). Viral method has high efficiency for gene 
transfection, but may cause insertional mutagenesis, immunogenicity. 
Furthermore, there is size limitation of used genes with this method. 
Chemical method is well used in many experiments, compare with other two 
methods, it is simple, cheap and low side effect (Douglas 2008).   
Because free DNA molecules are rejected by the cell membrane, vehicles 
are able to provide protection and transportation. DNAs are encapsulated in 
microcapsules, and then the capsules are delivered into cells. DNAs are 
released from the capsules inside the cell is the main objective of the 
transfection study. This transfection method with DNA plasmids is non-viral 
delivery.  
Neuraminidase loaded (DS/PArg)2 microcapsules were prepared with 
same method in above section. Amount of 100 μl DNA plasmid was 
encapsulated using neuraminidase in CaCO3 core particles co-precipitation 
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step. The final concentration of DNA in CaCO3 solution is 0.05 mg/ml. These 
capsules were premixed with culture medium and then incubated with 
HUVECs. DNA plasmid was prepared by Dr. David Gould (Bone and Joint 
Research Unit, Barts and The London, Queen Mary's School of Medicine and 
Dentistry, University of London).  
To compare transfection efficiency between capsules contain DNA and 
commonly transfection protocols, a commercial transfection reagent Fugene 
6 is used as control (Hunt, Currie et al. 2010). Because amount of DNA lost 
during capsules fabrication is difficult to be measured, same amount of DNA 
plasmid were used in capsules fabrication and Fugene 6. The volume ratio of 
Fugene 6 to DNA plasmid is 3: 1, and Fugene 6 plus DNA plasmid to the 
culture medium is 1: 10. Fugene 6 was mixed with serum free medium M199, 
the solution was vortexed for 5 second and then incubate for 5 minutes. A 
certain amount of DNA plasmid was added to solution of Fugene 6 
transfection reagent and M199. Then the final mixed solution was incubated 
for 15 minutes. After that, the final mixture was added to endothelial cells. 
To deliver DNA into cells for expression of GFP, capsules have to pass 
cells membrane and deliver the plasmid DNA to the nucleus where gene 
transcripted. Capsules are not labeled with any fluorescent dyes, as any 
fluorescence may overlap with the fluorescence that generated by the cell. 
Samples were observed using CLSM after 12 hours, and 1, 2, 3, 5 days. 
For all samples, very few of transfected cells can be observed, and the 
intensity of green fluorescence is weak. As obvious degradation of 
(DS/PArg)2 capsules occurs after 3 days, the encapsulated DNA plasmids are 
released by during the period. Samples are observed before 3 days, may be 
not have sufficient time to express the fluorescent protein. Furthermore, the 
fluorescent proteins may be not remaining stable after 5 days. In Figure 8.18, 
the green fluorescent proteins in Fugene 6 sample distribute all around 
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cytoplasm region; while in capsules sample, GFPs have strong intensity in 
small area. 
FITC channel Transmitted light and FITC channel 
  
  
Figure 8.18: CLSM images of transfected endothelial cell observed after 72 hours 
co-incubation. 
Top images are HUVECs with commercial reagent Fugene 6; bottom images are HUVEC 
with capsules contain neuraminidase and DNA plasmids. 
Summarized from 5 samples of neuraminidase + DNA plasmid capsules 
with HUVECs, sample of 3 days has highest number of cell with GFP 
expression. In the 3 days sample, the cells with green fluorescent protein 
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shows in bottom images of Figure 8.18 are very few. For control sample of 
HUVECs with commercial transfection reagent Fugene 6 after 3 days, cells in 
top images of Figure 8.18 are also very few. For samples of both capsules 
and Fugene 6 at 1, 2 and 5 days, the transfection efficiencies are even lower. 
In sample at 12 hours, GFP expression cannot be observed.   
The problem of low transfection efficiency of HUVECs is because these 
cells are primary cells. The primary cells are more difficult to transfect, as 
they are more susceptible to toxic agents and able to degrade exogenous 
nucleic acids in the cytoplasm (van Beijnum, van der Linden et al. 2008). 
Michelle et al studied 9 commercially available chemical transfection 
reagents work with primary HUVECs. GFP expression of total cells is less 
than 10 % in most reagents samples after 24 hours co-incubation time. After 
48 hours co-incubation time, GFP expressions in these samples are still less 
than 10 %. The highest GFP expression sample is using Lipofectamine LTX 
reagent, but up to 40 % cells of the sample are died (Hunt, Currie et al. 2010). 
Because low transfection efficiency on HUVECs, the non-viral method of 
delivery DNA plasmid with neuraminidase loaded capsule does not compete 





In this work, we studied interactions between (PSS/PAH)2 and (DS/PArg)2 
microcapsules and vascular endothelial cells in vitro. We first established that 
these capsules will be blocked by the endothelial glycocalyx layer and cannot 
penetrate through the cell membrane into endothelial cells. When the 
glycocaly layer is abolished by neuraminidase, the pretreat endothelial cells 
are accessible by both (PSS/PAH)2 and (DS/PArg)2 capsules. Although the 
mechanisms involved in the uptake of capsules by endothelial cells are not 
yet fully understood, the endothelial glycocalyx layer plays an important role 
in the internalization of these capsules.  
To minimize destruction of the endothelial glycocalyx layer while achieving 
cross cell membrane transport of the capsules, we encapsulated 
neuraminidase inside (PSS/PAH)2 and (DS/PArg)2 capsules. By controlling 
the permeability of capsules to neuraminidase, we achieve gradual release of 
the enzyme through the porous membrane of the capsule. The 
neuraminidase molecules surrounding the capsules work as clippers to 
cleave the glycocalyx layer to open a channel for the capsule to go through. 
Neuraminidase-loaded capsules can pass through the endothelial cell 
membrane and remain in cytoplasm for many days with no apparent effect on 
cell viability. Of the two capsules studied, (DS/PArg)2 ones are biodegradable, 
This makes them an even more appropriate candidate as drug delivery 
carries.  
The novelty of the current study lies in the fact that we demonstrated the 
effect of the endothelial glycocalyx in the interaction between microcapsules 
and endothelial cells. Furthermore, we functionalized microcapsules by 
loading them with an enzyme to enable them to pass through the glycocalyx 
layer and achieve cell internalization. Results from our study show that 
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microcapsules can be functionalized to work as delivery carriers not only into 
phagocytic cells but also into other types of normal healthy cells. Vascular 
endothelial cells are chosen in this study due to the fact that these cells have 
the primary function of being the ‘barrier’ between the circulating blood and 
the tissue. Large particles, such as proteins and microcapsules, are not 
permeable through the endothelial cell lining in vivo. In conclusion, we have 
fabricated microcapsules that have the high potential to act as drug delivery 
carriers with the ability to pass through the endothelium barrier of blood 






9. General Conclusion 
  There are growing interests in the past decades in micro sized vehicles 
with the function of storing, targeting and controlled release of substances. 
However, delivering desired drugs by micro containers to live cells is a 
challenging topic in material science. Various drug delivery systems have 
been developed with particular biomedical applications. They deliver a 
defined quantity of a therapeutic payload to a specific target site or tissue, at 
a controlled release rate, with or without externally trigger mechanism, such 
as ultrasound or light. Micro sized capsules with controlled delivery and 
release to designated sites have been introduced as potential drug 
containing vesicles.  
The Layer-by-Layer (LbL) technique based on the sequential adsorption of 
oppositely charged polymers on a charged substrate has been developed to 
construct these microcapsules. Oppositely charged proteins and 
polyelectrolytes are sequentially absorbed onto a charged template by 
electrostatic attraction, resulting in complex formation between polyanions 
and polycations of defined thickness. Empty capsules can be obtained after 
decomposing the template. The size and morphology of the microcapsules, 
the polyelectrolytes and thickness of the shell, the permeability as well as the 
release activation mechanism can be controlled with the Layer-by-Layer 
method.  
The present work starts with microcapsules fabrication and 
functionalization. Biocompatible CaCO3 particles with porosity, uniform and 
almost spherical shape are used as template cores. Fluorescent dyes, 
neuraminidase and DNA plasmids are encapsulated by CaCO3 
co-precipitation method also called pre-loading. Gold nanoparticles and 
magnetite nanoparticles are coated as a capsule layer in the shell. 
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The main research outcome of the thesis is making a further step on drug 
delivery system with microcapsules in vitro. Investigating interactions 
between epithelial cells (Caco-2 cell line) and capsules with magnetite 
nanoparticles is performed with physical method. Epithelial cells are 
incubated with iron nanoparticles functionalized capsules with a magnet. 
Magnet provides magnetic field as an extra driving force attracts capsules 
with magnetite nanoparticles toward to epithelial cells. The number of 
internalized capsules with magnetite nanoparticles by epithelial cells is 3 
times higher than control capsules. After magnet treatment for 10 minutes, 
1.8 adhered capsules with magnetite nanoparticles per cell are observed with 
CLSM.   
Investigating interactions between non-phagocytic cell of HUVECs and 
capsules is performed with biochemical stimuli. Neuraminidase encapsulated 
(PSS/PAH)2 and (DS/PArg)2 capsules as well as control capsules are 
prepared for the experiments. Capsules are first mixed with culture medium 
then added to HUVECs. The glycocalyx layer on cell membrane shows 
negative charge, thus capsules outmost layer is prepared with positive 
charge. However, the culture medium changes the surface charge of 
microcapsules to negative. Therefore, capsules cannot adhere with HUVECs 
by electrostatic attraction between ions of opposite charge. 
Toxicity of capsules is studied before neuraminidase encapsulation. 
Capsules are sterilized using autoclaving process. These capsules are 
incubated with cells for up to 14 days. Comparing SEM images of 
co-incubation time of 2, 4, 7, 14 days samples, cells viability are not obviously 
affected by these capsules. Most capsules are dispersed in a circle shape 
around cell nucleus.  
After pretreat HUVECs with neuraminidase, control capsules are observed 
under the glycocalyx layer. Therefore, HUVECs are able to internalize 
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capsules without the glycocalyx layer. After neuraminidase encapsulation and 
capsules fabrication, ~40% of neuraminidase added for CaCO3 
co-precipitation is remaining in the entire hollow capsules. The release rate of 
neuraminidase loaded (PSS/PAH)2 capsules is 12μg/h in first 2 hours. The 
amount of released enzyme in the 2 hours is sufficient to cleave glycocalyx 
around capsules. After 2 hours co-incubation, images of CLSM show ~4 
neuraminidase loaded capsules are internalized per cell, while no control 
capsule can be observed in the cell. Images taken from SEM with focused ion 
beam shows neuraminidase loaded capsules below cell membrane at the 
cross section of the milled area.  
Synthetic (PSS/PAH)2 capsules are not degraded after 7 days internalized 
by HUVECs. Biodegradable capsules of (DS/PArg)2 are used to study the 
degradation of HUVECs. After 3 days of (DS/PArg)2 capsules internalized by 
cells, capsules shape are changed and turned into segments. After 7 days, 
the internalized capsules became polymer pieces and dispersed widely in 
cell cytoplasm region. Images from SEM with focused ion beam also show 
similar result. Neuraminidase loaded DS/PArg capsule are used as a vehicle 
to deliver DNA plasmids into HUVECs. After 48 hours co-incubation, number 
of cells with GFP expression is very few. The non-viral transfection method 
with capsules does not compete with commercial reagents method.  
In summary, this work has provided a detailed analysis of deliver 
polyelectrolyte multilayer capsules into normal healthy human umbilical vein 
endothelial cells. Glycocalyx of HUVECs is essential barrier for substance 
absorption. These neuraminidase loaded microcapsules may able to apply to 
other non-immune and non-phagocytic types of cell. Neuraminidase loaded 
microcapsules are able to pass the membrane of endothelial cells, and may 
penetrate the cell layer. As endothelial cells cover the interior of capillary, 
capsules may diffuse into tissues or organs. Therefore, these multifunctional 
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microcapsules have huge potentials in drugs encapsulation and delivery 
system. Although the reason for capsules internalization by cells is not fully 
understand yet, the results presented in this thesis contribute a step in field of 
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